Código;Control Group;Treated Group;Intervention Target;Control Freezing %;Treated Freezing %;Control SEM;Treated SEM;Control Sample Size;Treated Sample Size;Control SD;Treated SD;Significant;p Value;Pooled SD;Effect Size (in Cohen's D);Effect Size (in %);Result Description;Descriptor Term;Graph Code;Protocol Code;Power (upper-bound ES);Power (intermediate);Power (lower-bound ES);Normalized Effect Size;Weighted Mean (Control+Treated);Pooled Coefficient of Variation;Contextual Baseline Freezing (Control);Contextual Baseline Freezing  (Treated);Contextual Baseline SEM (Control);Contextual Baseline SEM (Treated);Tone Baseline (Control);Tone Baseline (Treated);Tone Baseline SEM (Control);Tone Baseline SEM (Treated);Description Score;ES_Absolute Difference;Power_upper_AbsES;Power_lower_AbsES;Power_interm_AbsES;Power_d02;Power_d05;Power_d08
1;dys+/+;dys+/-;Dysbindin 1 k.o.;38,98;28,084;4,19;3,77;16;16;16,76;15,08;WAHR;<0.05;15,9421454;-0,683471373;-27,95279631;dys +/+ mice froze significantly more than both dys +/- and dys -/-;significantly more;1;74;0,884362768;0,730651008;0,533086522;27,95279631;33,532;0,475430795;2,04;2,72;1,02;2,04;;;;;0,71;-10,896;0,983099151;0,729345576;0,857766992;0,087390985;0,292988936;0,618982436
2;dys+/+;dys-/-;Dysbindin 1 k.o.;38,98;22,63;4,19;2,3;16;16;16,76;9,2;WAHR;<0.01;13,51920116;-1,209390984;-41,94458697;dys +/+ mice froze significantly more than both dys +/- and dys -/-;significantly more;1;74;0,961040902;0,859087025;0,673322387;41,94458697;30,805;0,438863858;2,04;0,34;1,02;0,34;;;;;0,71;-16,35;0,997841957;0,858043548;0,946675284;0,087390985;0,292988936;0,618982436
3;CT Contextual;KO Contextual;inducible NMDA receptor knockout mice;52;21;6;5;4;5;12;11,18033989;WAHR;<0.05;11,53875458;-2,686598436;-59,61538462;As expected, dox-induced NMDA receptor knockout caused significant behavioral impairment in learning trace fear conditioning as revealed byreduced contextual and tone freezing;significant impairment;2;75;0,865807874;0,705797419;0,509822977;59,61538462;34,77777778;0,331785275;;;;;;;;;1,07;-31;0,844407831;0,465011673;0,597418648;0,06024379;0,115669751;0,222232831
4;CT Tone;KO Tone;inducible NMDA receptor knockout mice;51;31;4;7;4;5;8;15,65247584;WAHR;<0.01;12,93941928;-1,54566442;-39,21568627;As expected, dox-induced NMDA receptor knockout caused significant behavioral impairment in learning trace fear conditioning as revealed byreduced contextual and tone freezing;significant impairment;3;76;0,764924673;0,59000179;0,411362249;39,21568627;39,88888889;0,324386556;;;;;;;;;1,07;-20;0,755203408;0,385815283;0,503143422;0,06024379;0,115669751;0,222232831
7;DMSO;100uM IU1;inibidor ubiquitin-specific protease 14;17,86;9,09;3,56;1,22;10;10;11,25770847;3,857978745;WAHR;=0.026;8,414867795;-1,042202945;-49,10414334;revealed significant impairments in retention for the training context in animals that received either 100 mM or 200 mM;significant impairment;4;1;0,581834733;0,423551726;0,288801283;49,10414334;13,475;0,624479985;;;;;;;;;1,07;-8,77;0,999983696;0,970650311;0,995040987;0,073209713;0,200955551;0,432157628
8;DMSO;200uM IU1;inibidor ubiquitin-specific protease 14;17,86;4,54;3,56;0,66;10;10;11,25770847;2,087103256;WAHR;=0.02;8,096048419;-1,645247077;-74,58006719;evealed significant impairments in retention for the training context in animals that received either 100 mM or 200 mM;significant impairment;4;1;0,614815242;0,450935644;0,307863492;74,58006719;11,2;0,722861466;;;;;;;;;1,07;-13,32;0,999994467;0,979427487;0,997086886;0,073209713;0,200955551;0,432157628
9;DMSO;100uM IU1;inibidor ubiquitin-specific protease 14;48,2;42,9;7,07;6,56;10;10;22,35730306;20,74454145;FALSCH;NS;21,56600334;-0,245757172;-10,99585062;we did not find a significant effect of the drug on the auditory CS test;did not find significant effect;5;2;0,626074528;0,460495277;0,314604964;10,99585062;45,55;0,473457812;;;;;;;;;0,57;-5,3;0,664889103;0,323898288;0,425131373;0,073209713;0,200955551;0,432157628
10;DMSO;200uM IU1;inibidor ubiquitin-specific protease 14;48,2;40,88;7,07;5,55;10;10;22,35730306;17,55064101;FALSCH;NS;20,098184;-0,36421201;-15,18672199;we did not find a significant effect of the drug on the auditory CS test;did not find significant effect;5;2;0,687252216;0,514608619;0,353710235;15,18672199;44,54;0,451238976;;;;;;;;;0,57;-7,32;0,725771478;0,364154646;0,476257607;0,073209713;0,200955551;0,432157628
11;NTg 2 meses;Tg 2 meses;rTg4510 (expressa ptn tau humana com mutação P301L);49,88;27,42;6,53;3,13;24;24;31,99033604;15,33380579;WAHR;<0.01;25,08492775;-0,895358369;-45,02806736;rTg4510 mice displayed a decrease in the amount of time freezing when returned to the same environment in which they previously received a mild electrical shock;decrease;6;3;0,881890234;0,72724866;0,529846698;45,02806736;38,65;0,649027885;;;;;;;;;0,57;-22,46;0,888312247;0,516402016;0,654949834;0,106543506;0,409968112;0,791409379
12;NTg 6 meses;Tg 6 meses;rTg4510 (expressa ptn tau humana com mutação P301L);43,35;19,85;4,7;4,44;26;21;23,96539171;20,34663609;WAHR;<0.001;22,42925272;-1,047738874;-54,20991926;rTg4510 mice displayed a decrease in the amount of time freezing when returned to the same environment in which they previously received a mild electrical shock;decrease;6;3;0,852505224;0,68884627;0,494457247;54,20991926;32,85;0,682777861;;;;;;;;;0,57;-23,5;0,937811999;0,595607554;0,737462043;0,104699078;0,399185828;0,778382185
13;NTg 10 meses;Tg 10 meses;rTg4510 (expressa ptn tau humana com mutação P301L);52,76;2,87;5,48;1,56;14;16;20,50428248;6,24;WAHR;<0.001;14,69887848;-3,394136503;-94,56027293;rTg4510 mice displayed a decrease in the amount of time freezing when returned to the same environment in which they previously received a mild electrical shock;decrease;6;3;0,99408918;0,954637345;0,825709428;94,56027293;26,152;0,562055616;;;;;;;;;0,57;-49,89;0,989764274;0,768443673;0,88785647;0,08485747;0,276795249;0,589436499
14;NTg 2 meses;Tg 2 meses;rTg4510 (expressa ptn tau humana com mutação P301L);64,81;63;2,59;2,59;24;24;12,68835687;12,68835687;FALSCH;NS;12,68835687;-0,142650464;-2,792778892;essa comparação não é mencionada no texto;-;7;11;1;0,99999815;0,99945626;2,792778892;63,905;0,198550299;;;;;;;;;;-1,81;0,999992272;0,977033682;0,996565388;0,106543506;0,409968112;0,791409379
15;NTg 6 meses;Tg 6 meses;rTg4510 (expressa ptn tau humana com mutação P301L);52,11;27,74;6,48;5,44;26;21;33,04164645;24,92921178;WAHR;<0.001;29,71085548;-0,82023892;-46,76645557;rTg4510 mice exhibited a decrease in the amount of time freezing in response to an auditory tone;decrease;7;11;0,779047792;0,604752935;0,423156546;46,76645557;41,2212766;0,72076505;;;;;;;;;0,57;-24,37;0,751655297;0,383113023;0,499813994;0,104699078;0,399185828;0,778382185
16;NTg 10 meses;Tg 10 meses;rTg4510 (expressa ptn tau humana com mutação P301L);32,92;1,55;3,63;0,77;14;16;13,58221631;3,08;WAHR;<0.001;9,525326766;-3,293325339;-95,29161604;rTg4510 mice exhibited a decrease in the amount of time freezing in response to an auditory tone;decrease;7;11;0,990640909;0,940138221;0,796650297;95,29161604;16,18933333;0,588370538;;;;;;;;;0,57;-31,37;0,999998265;0,985981443;0,998357652;0,08485747;0,276795249;0,589436499
17;GFP;CREB;CREB overexpression;26,63;44,54;5,25;4,56;12;10;18,18653348;14,41998613;WAHR;=0,006;16,59770165;1,079065065;67,25497559;mice microinjected with CREB vector froze significantly more than mice with GFP or CREBS133A vector, which did not differ from each other;significantly more;8;12;0,816223949;0,645567605;0,456829366;40,21104625;34,77090909;0,477344484;;;;;;;;;0,71;17,91;0,899343752;0,531497137;0,67126748;0,075347113;0,214998359;0,463585727
18;GFP;CREB S133A;CREB dominante-negativo;26,63;24,35;5,25;3,42;12;11;18,18653348;11,34285678;FALSCH;=0,83;15,31394323;-0,148883927;-8,561772437;mice microinjected with CREB vector froze significantly more than mice with GFP or CREBS133A vector, which did not differ from each other;did not differ;8;12;0,476835868;0,341491148;0,233600153;8,561772437;25,53956522;0,599616442;;;;;;;;;0,14;-2,28;0,949458191;0,620510271;0,761756625;0,076687438;0,22378312;0,482726232
22;Spir-1 +/+ machos;Spir-1 gt/gt machos;k.o. para spir-1;49,66;72,76;4,83;4,83;9;4;14,49;9,66;WAHR;=0.011;13,34720808;1,730699024;46,51631091;when re-exposed to both context and cue, only spir-1 mutant male mice showed a significant increase in fear memory;significant increase;10;14;0,985415753;0,921813634;0,764169652;31,7482133;56,76769231;0,235119793;;;;;;;;;1,07;23,1;0,818291912;0,43913104;0,567332871;0,062783492;0,132297238;0,265276863
23;Spir-1 +/+ fêmeas;Spir-1 gt/gt fêmeas;k.o. para spir-1;57,32;64,44;5,5;5,15;5;8;12,29837388;14,56639969;FALSCH;NS;13,78490611;0,516506964;12,42149337;essa comparação não é mencionada no texto;-;10;80;0,962731521;0,862774654;0,67807089;11,04903786;61,70153846;0,223412681;;;;;;;;;;7,12;0,833487408;0,453847815;0,584529718;0,064215087;0,141701906;0,289261208
24;Spir-1 +/+ machos;Spir-1 gt/gt machos;k.o. para spir-1;15,52;40,69;4,83;7,24;9;4;14,49;14,48;WAHR;=0.013;14,48727341;1,737386966;162,1778351;when re-exposed to both context and cue, only spir-1 mutant male mice showed a significant increase in fear memory;significant increase;11;15;0,568961665;0,413095438;0,281614641;61,85795036;23,26461538;0,622717082;;;;;;;;;1,07;25,17;0,75273383;0,383931633;0,500823347;0,062783492;0,132297238;0,265276863
25;Spir-1 +/+ fêmeas;Spir-1 gt/gt fêmeas;k.o. para spir-1;11,24;32,35;3,091;8,59;5;8;6,911686118;24,296189;FALSCH;=0.098;19,82473024;1,064831639;187,8113879;essa comparação não é mencionada no texto;-;11;81;0,25732773;0,186820037;0,135061232;65,25502318;24,23076923;0,81816347;;;;;;;;;;21,11;0,530318124;0,249519998;0,32708129;0,064215087;0,141701906;0,289261208
26;H2O Adolescent;EtOH Adolescent;EtOH Adolescent Exposure;63,65;47,31;4,64;4,64;10;10;14,67296834;14,67296834;WAHR;<0.05;14,67296834;-1,113612435;-25,67164179;adolescent EtOH-exposed animals showed significantly less freezing to the context at test after context conditioning than their H20-exposed counterparts and both adult exposure groups;significantly less;12;16;0,993206897;0,950660692;0,817367167;25,67164179;55,48;0,264473114;;;;;;;;;0,79;-16,34;0,939021982;0,598033556;0,739864667;0,073209713;0,200955551;0,432157628
27;H2O Adult;EtOH Adult;EtOH Adult Exposure;63,31;65,89;3,09;3,44;10;10;9,77143797;10,87823515;FALSCH;NS;10,33965667;0,249524726;4,075185595;adolescent EtOH-exposed animals showed significantly less freezing to the context at test after context conditioning than their H20-exposed counterparts and both adult exposure groups;not significant;12;16;0,999997252;0,99958875;0,98775413;3,915616937;64,6;0,160056605;;;;;;;;;0,71;2,58;0,998720218;0,879735116;0,958521414;0,073209713;0,200955551;0,432157628
28;0 mg/kg/d BPA;0,4 mg/kg/d BPA;bisphenol-A exposure;24,38;17,71;2,83;6,44;10;10;8,949245778;20,36506813;FALSCH;NS;15,72935154;-0,424047996;-27,35849057;essa comparação não é mencionada no texto;-;13;17;0,352984224;0,25212212;0,17601995;27,35849057;21,045;0,747415136;2,83;3,35;0,51;0,77;;;;;;-6,67;0,905090336;0,539824837;0,680153022;0,073209713;0,200955551;0,432157628
29;0 mg/kg/d BPA;4 mg/kg/d BPA;bisphenol-A exposure;24,38;49,7;2,83;6,44;10;10;8,949245778;20,36506813;WAHR;<0.05;15,72935154;1,609729424;103,8556194;freezing time was significantly extended, sugesting enhanced acquisition;enhanced;13;17;0,897126304;0,748715769;0,550605385;50,94567404;37,04;0,424658519;2,83;2,32;0,51;0,51;;;;;1,14;25,32;0,905090336;0,539824837;0,680153022;0,073209713;0,200955551;0,432157628
30;0 mg/kg/d BPA;40 mg/kg/d BPA;bisphenol-A exposure;24,38;84;2,83;11,08;10;10;8,949245778;35,03803647;WAHR;<0.01;25,57100898;2,331546638;244,5447088;freezing time was significantly extended, sugesting enhanced acquisition;enhanced;13;17;0,91822321;0,780753073;0,58313438;70,97619048;54,19;0,471876896;2,83;3,35;0,51;0,51;;;;;1,14;59,62;0,520833209;0,244817914;0,320742695;0,073209713;0,200955551;0,432157628
32;WT;Tg;k.o. para SARM-1;40,13;30,01;3,68;1,7;26;26;18,76439181;8,668333173;WAHR;=0.011;14,61578599;-0,692402038;-25,21804137;displayed reduced levels of freezing in response to the environmental cues / These results suggest that the Sarm1 knockdown mice were impaired in hippocampus-dependent contextual memory;impaired / impairment;14;18;0,994754543;0,957796222;0,832573969;25,21804137;35,07;0,416760365;8,51;7,94;2,83;1,7;;;;;0,93;-10,12;0,999898938;0,946796715;0,987885594;0,111369148;0,437632237;0,822381634
33;WT;Tg;k.o. para SARM-1;53,44;36,7;5,36;5,65;13;11;19,32575484;18,73893007;WAHR;=0.043;19,06125604;-0,878221244;-31,3248503;had lower freezing responses / suggesting an impairment in cued fear conditioning;impaired / impairment;15;19;0,877805808;0,721692006;0,524594163;31,3248503;45,7675;0,416480167;4,22;6,47;1,41;1,41;;;;;0,93;-16,74;0,838100419;0,458499555;0,589916788;0,077720929;0,230543296;0,497177982
35;vehicle;RG108;DNA methyltransferase inhibitors;88,94;86,67;1,83;3,67;6;6;4,482566229;8,989627356;FALSCH;NS;7,10305568;-0,319580769;-2,552282438;no significant difference in freezing between groups;no significant difference;17;26;1;1;0,999995637;2,552282438;87,805;0,0808958;;;;;;;;;0,64;-2,27;0,999869354;0,942182591;0,986270269;0,063856988;0,1393477;0,283285026
36;vehicle;5-AZA;DNA methyltransferase inhibitors;88,94;88,69;1,83;1,63;6;6;4,482566229;3,992668281;FALSCH;NS;4,244690801;-0,058897105;-0,281088374;no significant difference in freezing between groups;no significant difference;17;26;1;1;1;0,281088374;88,815;0,047792499;;;;;;;;;0,64;-0,25;1;0,999961362;0,999999727;0,063856988;0,1393477;0,283285026
39;vehicle;anisomycin;protein translation inhibitor;83,4;71,78;4,14;7,05;10;7;13,09182951;18,65254674;FALSCH;0.094;15,55649704;-0,746954792;-13,93285372;essa comparação não é mencionada no texto;-;19;28;0,998677252;0,981699759;0,895009546;13,93285372;78,61529412;0,197881306;2,09;0,95;0,38;0;;;;;;-11,62;0,851172532;0,472203689;0,60564951;0,06907288;0,173703395;0,368376937
40;vehicle;β-lac (clasto-lactacystin- β-lactone);proteasome inhibitor;83,4;75,1;4,14;4,14;10;10;13,09182951;13,09182951;FALSCH;0.094;13,09182951;-0,633983202;-9,952038369;essa comparação não é mencionada no texto;-;19;28;0,999997223;0,999586067;0,987708565;9,952038369;79,25;0,165196587;2,09;0,95;0,38;0;;;;;;-8,3;0,975587406;0,696696563;0,830787182;0,073209713;0,200955551;0,432157628
41;vehicle;anisomycin;protein translation inhibitor;71,78;46,05;7,05;8,29;9;10;21,15;26,2152818;WAHR;0.032;23,96535367;-1,073633227;-35,84563945;The drug-treated groups were collapsed and a planned comparison between the collapsed drug groups and the vehicle group revealed a significant reduction in CS freezing for drug-treated animals trained with TFC but not DFC;significant reduction;20;30;0,845148466;0,679743357;0,48635948;35,84563945;58,23789474;0,411507898;1,16;1,36;0,58;0,39;;;;;1,21;-25,73;0,551625229;0,260299636;0,341554249;0,071974211;0,192823661;0,41350208
42;vehicle;β-lac (clasto-lactacystin- β-lactone);proteasome inhibitor;71,78;52,69;7,05;8,71;9;11;21,15;28,88780192;WAHR;0.032;25,73759788;-0,741716461;-26,59515185;The drug-treated groups were collapsed and a planned comparison between the collapsed drug groups and the vehicle group revealed a significant reduction in CS freezing for drug-treated animals trained with TFC but not DFC;significant reduction;20;30;0,808558644;0,636892055;0,44953563;26,59515185;61,2805;0,419996538;1,16;1,36;0,58;0,39;;;;;1,21;-19,09;0,511651295;0,240319546;0,314664615;0,072974857;0,19941046;0,42863838
43;vehicle;anisomycin;protein translation inhibitor;59,39;31,49;9,66;10,22;10;7;30,5476022;27,0395784;WAHR;0.027;29,19501875;-0,955642476;-46,97760566;Planned comparisons revealed significantly lower context freezing in the drug-treated groups compared to the vehicle infusedgroup for animals trained with delay but not trace fear conditioning;significantly lower;21;29;0,469937929;0,336329474;0,230211369;46,97760566;47,90176471;0,609476894;2,09;0,95;0,38;0;;;;;0,79;-27,9;0,359364684;0,171839466;0,220639145;0,06907288;0,173703395;0,368376937
44;vehicle;β-lac (clasto-lactacystin- β-lactone);proteasome inhibitor;59,39;38,67;9,66;9,66;10;10;30,5476022;30,5476022;WAHR;0.027;30,5476022;-0,678285643;-34,88802829;Planned comparisons revealed significantly lower context freezing in the drug-treated groups compared to the vehicle infusedgroup for animals trained with delay but not trace fear conditioning;significantly lower;21;29;0,50984728;0,366552114;0,250183324;34,88802829;49,03;0,623039001;2,09;0,95;0,38;0;;;;;0,79;-20,72;0,391544665;0,1855067;0,239602947;0,073209713;0,200955551;0,432157628
45;vehicle;anisomycin;protein translation inhibitor;50,65;58,06;13,01;7,75;9;10;39,03;24,50765187;FALSCH;0.849;32,16899512;0,23034602;14,62981244;essa comparação não é mencionada no texto;-;22;31;0,433858764;0,309718928;0,212874727;12,76265932;54,55;0,589715768;1,16;1,36;0,58;0,39;;;;;;7,41;0,343620056;0,165274581;0,211501709;0,071974211;0,192823661;0,41350208
46;vehicle;β-lac (clasto-lactacystin- β-lactone);proteasome inhibitor;50,65;47,73;13,01;9,69;9;11;39,03;32,13809422;FALSCH;0.849;35,36735642;-0,082562009;-5,765054294;essa comparação não é mencionada no texto;-;22;31;0,306943658;0,220373977;0,156020435;5,765054294;49,044;0,721135234;1,16;1,36;0,58;0,39;;;;;;-2,92;0,304488738;0,149260822;0,189145846;0,072974857;0,19941046;0,42863838
48;YFP;TET1;virus to overexpress enzyme methylcytosine dioxygenase;40,47;28,09;7,14;5,95;9;9;21,42;17,85;FALSCH;NS;19,71596942;-0,627917387;-30,59056091;all groups exhibited similar levels of freezing behavior;similar levels;24;33;0,511123671;0,367533592;0,250837354;30,59056091;34,28;0,575144965;0,46;0,73;0,11;0,41;;;;;0;-12,38;0,696998576;0,34445364;0,451420307;0,070863494;0,1855067;0,396438439
49;YFP;TET1m;virus to express catalytically inactive version;40,47;37,85;7,14;4,04;9;9;21,42;12,12;FALSCH;NS;17,40274116;-0,150550995;-6,473931307;all groups exhibited similar levels of freezing behavior;similar levels;24;33;0,614871611;0,450983225;0,307896931;6,473931307;39,16;0,444400949;0,46;0,35;0,11;0,14;;;;;0;-2,62;0,800905723;0,423304756;0,548583165;0,070863494;0,1855067;0,396438439
50;YFP;TET1;virus to overexpress enzyme methylcytosine dioxygenase;42,65;32,45;4,76;3,33;17;21;19,62598278;15,25997706;WAHR;<0.01;17,33670256;-0,588347177;-23,91559203;they similarly disrupted the formation of long-term memory formation after context fear conditioning;disrupted;25;34;0,930860783;0,801595308;0,605461434;23,91559203;37,01315789;0,468392959;0,46;0,73;0,11;0,41;;;;;1,5;-10,2;0,982490716;0,726359406;0,85536777;0,094039947;0,334775163;0,688681788
51;YFP;TET1m;virus to express catalytically inactive version;42,65;28,29;4,76;3,33;17;21;19,62598278;15,25997706;WAHR;<0.05;17,33670256;-0,828300535;-33,66940211;they similarly disrupted the formation of long-term memory formation after context fear conditioning;disrupted;25;34;0,930860783;0,801595308;0,605461434;33,66940211;34,71421053;0,499412266;0,46;0,35;0,11;0,14;;;;;1,5;-14,36;0,982490716;0,726359406;0,85536777;0,094039947;0,334775163;0,688681788
52;vehicle;rapamycin;mTOR kinase inhibitor;36,94;21,68;5,27;5,27;11;11;17,47861265;17,47861265;WAHR;0.045;17,47861265;-0,873067005;-41,31023281;Follow up t-test revealed that RAP-treated animals exhibited significantly less freezing than VEH-treated animals;significantly less;26;35;0,618936935;0,454422069;0,310316724;41,31023281;29,31;0,596336153;;;;;;;;;0,79;-15,26;0,870218289;0,493761889;0,62997525;0,075561084;0,216401986;0,46667114
53;vehicle;rapamycin;mTOR kinase inhibitor;30,48;29,71;5,01;6,36;10;12;15,84301108;22,03168627;FALSCH;0.958;19,49148045;-0,039504439;-2,526246719;In follow up t-tests, memory in both groups were comparable when tested 1-h following training;were comparable;27;36;0,384998216;0,274615121;0,190314856;2,526246719;30,06;0,648419177;;;;;;;;;0;-0,77;0,787312515;0,411584719;0,53453045;0,075347113;0,214998359;0,463585727
54;vehicle;rapamycin;mTOR kinase inhibitor;45,33;20,06;9,45;7,33;10;12;29,88352389;25,39186484;WAHR;0.038;27,50403589;-0,918774252;-55,74674608;However, while short-term memory was spared, long-term memory was significantly decreased in RAP-treated animals relative to controls;were significantly decreased;28;35;0,419741792;0,299472608;0,206255493;55,74674608;31,54636364;0,871860738;;;;;;;;;1,14;-25,27;0,497621124;0,233543067;0,305482958;0,075347113;0,214998359;0,463585727
55;vehicle;rapamycin;mTOR kinase inhibitor;29,68;32,81;3,43;6,25;12;12;11,88186854;21,65063509;FALSCH;0.529;17,46322994;0,179233739;10,5458221;essa comparação não é mencionada no texto;-;29;37;0,556050225;0,402729654;0,274537611;9,539774459;31,245;0,558912784;;;;;;;;;;3,13;0,897520145;0,52892433;0,668505477;0,077917485;0,231827529;0,499895874
56;vehicle;anisomysin;protein synthesis inhibitor;29,68;3,59;3,43;1,71;12;12;11,88186854;5,923613762;WAHR;<0.0001;9,387971027;-2,779088253;-87,90431267;Post hoc Fisher’s LSD tests revealed that auditory fear memory was significantly effaced in ANISO-treated animals relative to all other groups;significantly effaced;29;37;0,942393936;0,822034397;0,628413746;87,90431267;16,635;0,564350528;;;;;;;;;0,79;-26,09;0,999973699;0,965676542;0,993728962;0,077917485;0,231827529;0,499895874
57;vehicle;rapamycin 3h post-training;mTOR kinase inhibitor;26,36;21,73;6,3;3,47;12;12;21,82384018;12,0204326;FALSCH;0.526;17,61775809;-0,262803018;-17,56449165;essa comparação não é mencionada no texto;-;30;88;0,38723247;0,276199059;0,191325921;17,56449165;24,045;0,732699442;;;;;;;;;;-4,63;0,892371358;0,521829415;0,660847917;0,077917485;0,231827529;0,499895874
60;vehicle;CIQ 3ug;GluN2C/GluN2D-selective potentiator;28,43;30,18;3,19;2,85;8;7;9,022682528;7,540391237;FALSCH;NS;8,37122636;0,209049418;6,155469574;"the level of fear
in CIQ -3 mice was similar to the vehicle group";similar;33;41;0,888763695;0,736782186;0,538971534;5,798542081;29,24666667;0,286228392;;;;;7,26;3,83;3,56;2,05;0;1,75;0,999597444;0,91689872;0,976277907;0,067276248;0,161858992;0,339585243
61;vehicle;CIQ 10ug;GluN2C/GluN2D-selective potentiator;28,43;44,7;3,19;5,02;8;8;9,022682528;14,19870417;WAHR;<0.05;11,89562945;1,367729221;57,22827999;CIQ-10 and CIQ-30 mice showed higher levels of conditioned freezing when compared with the vehicle group;higher levels;33;41;0,929327462;0,798987449;0,602611578;36,39821029;36,565;0,325328304;;;;;7,26;2,32;3,56;0;0,79;16,27;0,971848553;0,683048421;0,819031797;0,068522551;0,170075046;0,359622486
62;vehicle;CIQ 30ug;GluN2C/GluN2D-selective potentiator;28,43;43,59;3,19;5,25;8;8;9,022682528;14,8492424;WAHR;<0.05;12,28635015;1,233889627;53,32395357;CIQ-10 and CIQ-30 mice showed higher levels of conditioned freezing when compared with the vehicle group;higher levels;33;41;0,899589176;0,752305915;0,554153713;34,77861895;36,01;0,341192728;;;;;7,26;7,94;3,56;3,42;0,79;15,16;0,962922528;0,65496956;0,793994823;0,068522551;0,170075046;0,359622486
63;WT;OX1R-/-;Orexin Receptor-1 KO;43,33;27,11;4,44;4;15;16;17,19604606;16;WAHR;0.0088;16,58817194;-0,977805153;-37,43364874;mice also showed a significantly shorter freezing time in the periods of both presence and absence of CS compared with wild-type mice;significantly shorter;34;42;0,912748888;0,772141405;0,574191023;37,43364874;34,9583871;0,474511936;;;;;;;;;0,71;-16,22;0,971259882;0,681017614;0,817259174;0,086164452;0,285166162;0,604887941
64;WT;OX2R-/-;Orexin Receptor-2 KO;43,33;42,88;4,44;6,22;15;15;17,19604606;24,08995641;FALSCH;NS;20,9288079;-0,021501464;-1,038541426;essa comparação não é mencionada no texto;-;34;42;0,735112732;0,560010718;0,387931369;1,038541426;43,105;0,485530864;;;;;;;;;;-0,45;0,853366577;0,474585218;0,608362402;0,085015664;0,277810304;0,591330511
65;WT;OX1R-/-;Orexin Receptor-1 KO;59,76;35,28;5,71;6,85;19;17;24,88931297;28,24327354;WAHR;0.01;26,5205371;-0,923058229;-40,96385542;While Ox1r /  mice showed decreased freezing behavior in both the cued and contextual fearconditioning tests, Ox2r /  mice showed impairment only in the contextual fear-conditioning test;decreased / impairment;35;43;0,868905282;0,709842549;0,513547652;40,96385542;48,2;0,550218612;;;;;;;;;0,57;-24,48;0,738560064;0,373361815;0,487740775;0,092022251;0,322212516;0,668707756
66;WT;OX2R-/-;Orexin Receptor-2 KO;59,76;33,66;5,71;5,71;19;15;24,88931297;22,11473491;WAHR;0.01;23,71541113;-1,100550181;-43,6746988;While Ox1r /  mice showed decreased freezing behavior in both the cued and contextual fearconditioning tests, Ox2r /  mice showed impairment only in the contextual fear-conditioning test;decreased / impairment;35;43;0,914733359;0,775236726;0,577387706;43,6746988;48,24529412;0,491559054;;;;;;;;;0,57;-26,1;0,802101237;0,424361667;0,549843472;0,089210404;0,304530989;0,639171409
67;WT;KO+ChR2;(virus control) KO+ChR2 in locus coeruleus;43,28;31,22;4,65;6,2;7;7;12,3027436;16,40365813;FALSCH;NS;14,49892237;-0,831785955;-27,8650647;essa comparação não é mencionada no texto;-;36;42;0,722195909;0,547449114;0,378320523;27,8650647;37,25;0,389232815;;;;;;;;;;-12,06;0,843529467;0,464093913;0,596364217;0,066187007;0,154681378;0,321847795
68;WT;KO+OX1R;KO+OX1R in locus coeruleus;43,28;55,13;4,65;8,06;7;8;12,3027436;22,79712263;WAHR;0.043;18,70028095;0,633680319;27,37985213;the KO-OX1R group showed an increase of freezing time in the test period;increase of freezing;36;42;0,739036309;0,563875724;0,3909118;21,49464901;49,6;0,377021793;;;;;;;;;0,71;11,85;0,661856699;0,322025945;0,422718315;0,067276248;0,161858992;0,339585243
69;WT;WT+OX1R;control+OX1R in locus coeruleus;43,28;43,06;4,65;8,06;7;7;12,3027436;21,32475557;FALSCH;NS;17,40837011;-0,012637599;-0,50831793;KO-OX1R group showed an increase of freezing time in the test period to a level comparable to that in wild-type mice;comparable;36;42;0,564880997;0,409806429;0,279364108;0,50831793;43,17;0,403251566;;;;;;;;;0;-0,22;0,695978679;0,343778891;0,450563337;0,066187007;0,154681378;0,321847795
70;WT;KO+ChR2;(virus control) KO+ChR2 in locus coeruleus;59,53;40,62;5,89;10,23;7;7;15,58347522;27,06603591;FALSCH;NS;22,08410062;-0,856272136;-31,76549639;we did not find any difference between the KO-OX1R and KO-ChR2 groups during both the conditioning and test periods;no differences;37;43;0,63389939;0,467206665;0,319366128;31,76549639;50,075;0,441020482;;;;;;;;;0,14;-18,91;0,495778169;0,232661358;0,304286095;0,066187007;0,154681378;0,321847795
71;WT;KO+OX1R;KO+OX1R in locus coeruleus;59,53;38,45;5,89;7,44;7;7;15,58347522;19,68438975;FALSCH;NS;17,75274486;-1,187422011;-35,41071729;we did not find any difference between the KO-OX1R and KO-ChR2 groups during both the conditioning and test periods;no differences;37;43;0,816963878;0,646412883;0,45754418;35,41071729;48,99;0,36237487;;;;;;;;;0,14;-21,08;0,678999763;0,332762009;0,436513386;0,066187007;0,154681378;0,321847795
72;WT;WT+OX1R;control+OX1R in locus coeruleus;59,53;55,81;5,89;7,44;7;7;15,58347522;19,68438975;FALSCH;NS;17,75274486;-0,209545061;-6,248950109;we did not find any difference between the KO-OX1R and KO-ChR2 groups during both the conditioning and test periods;no differences;37;43;0,816963878;0,646412883;0,45754418;6,248950109;57,67;0,307833273;;;;;;;;;0,14;-3,72;0,678999763;0,332762009;0,436513386;0,066187007;0,154681378;0,321847795
83;Zif268 +/+;Zif268 +/-;Zif268 knokout lines;56,83;56,83;2,97;2,97;10;10;9,391964651;9,391964651;FALSCH;NS;9,391964651;0;0;freezing performance of Zif268+/+ and Zif268+/- mice was undistinguishable. Zif268-/- mice, however, showed a clear deficit in freezing behavior 24 h after training;undistinguishable;44;50;0,999987599;0,998955759;0,979168738;0;56,83;0,165264203;;;;;;;;;0,14;0;0,999782862;0,931869507;0,982419322;0,073209713;0,200955551;0,432157628
84;Zif268 +/+;Zif268 -/-;Zif268 knokout lines;56,83;37,91;2,97;3,78;10;10;9,391964651;11,95340956;WAHR;<0.001;10,74925579;-1,760121851;-33,29227521;freezing performance of Zif268+/+ and Zif268+/- mice was undistinguishable. Zif268-/- mice, however, showed a clear deficit in freezing behavior 24 h after training;clear deficit;44;50;0,999705572;0,992682729;0,937263602;33,29227521;47,37;0,226921169;;;;;;;;;1,79;-18,92;0,997647695;0,854117536;0,944423286;0,073209713;0,200955551;0,432157628
85;Sal + Sal;Sal + IL1beta;interleukin-1beta injec;67,08;45,34;4,96;3,41;9;9;14,88;10,23;WAHR;<0.05;12,7684631;-1,70263248;-32,4090638;administration of IL-1b (5 ng/0.25 ll) in dorsal hippocampus caused a reduction of freezing response, an effect attenuated by pre-treatment with p38 inhibitor;reduction;45;51;0,999118505;0,98570646;0,908590032;32,4090638;56,21;0,227156433;;;;;;;;;0,57;-21,74;0,968758988;0,672701662;0,809937829;0,070863494;0,1855067;0,396438439
87;Sal + Sal;SB + Sal;p38 protein inhibitor;67,08;61,49;4,96;4,96;9;9;14,88;14,88;FALSCH;NS;14,88;-0,375672043;-8,333333333;injection of SB203580 alone had no significant effect on the freezing percentage during test;no significant effect;45;89;0,991926324;0,945240551;0,80647067;8,333333333;64,285;0,231469239;;;;;;;;;0,21;-5,59;0,906646693;0,542140922;0,682609357;0,070863494;0,1855067;0,396438439
88;Sal + Sal;DCS 3 + Sal;D-cycloserine 3mg/kg;56,48;51,54;5,24;6,48;7;7;13,86373687;17,1444685;FALSCH;NS;15,59063822;-0,316856817;-8,746458924;The dose of 15 mg/kg induced an increase in the percentage of time rats spent freezing 24 h after conditioning. Lower doses produced no changes on freezing during the test;no change;46;89;0,871588515;0,713378802;0,516822808;8,746458924;54,01;0,288662067;;;;;;;;;0,14;-4,94;0,788483204;0,412573392;0,535721343;0,066187007;0,154681378;0,321847795
89;Sal + Sal;DCS 7.5 + Sal;D-cycloserine 7.5mg/kg;56,48;52,46;5,24;5,86;7;7;13,86373687;15,50410268;FALSCH;NS;14,70680795;-0,273342796;-7,117563739;The dose of 15 mg/kg induced an increase in the percentage of time rats spent freezing 24 h after conditioning. Lower doses produced no changes on freezing during the test;no change;46;89;0,906559871;0,762669454;0,564528614;7,117563739;54,47;0,26999831;;;;;;;;;0,14;-4,02;0,833253495;0,453614339;0,584258716;0,066187007;0,154681378;0,321847795
90;Sal + Sal;DCS 15 + Sal;D-cycloserine 15mg/kg;56,48;75,3;5,24;5,24;7;7;13,86373687;13,86373687;WAHR;<0.05;13,86373687;1,357498355;33,32152975;The dose of 15 mg/kg induced an increase in the percentage of time rats spent freezing 24 h after conditioning. Lower doses produced no changes on freezing during the test;increase;46;89;0,996304165;0,965854589;0,85122032;24,99335989;65,89;0,210407298;;;;;;;;;0,71;18,82;0,873916011;0,498200119;0,634917807;0,066187007;0,154681378;0,321847795
91;Sal + Sal;Sal + IL1beta;interleukin-1beta injec;56,96;30,12;5,31;4,06;7;7;14,04893946;10,74175032;WAHR;<0.05;12,50515694;-2,146314527;-47,12078652;Treatment with DCS, at a dose that did not induce changes in freezing per se, reversed the effect of IL- 1b on contextual fear memory;reduction;47;90;0,973202164;0,88735526;0,711335783;47,12078652;43,54;0,28721077;;;;;;;;;0,57;-26,84;0,930888045;0,582328216;0,724175724;0,066187007;0,154681378;0,321847795
93;Sal + Sal;DCS 7.5 + Sal;D-cycloserine 7.5mg/kg;56,96;53,35;5,31;5,62;7;7;14,04893946;14,86912237;FALSCH;NS;14,46484532;-0,249570591;-6,337780899;Treatment with DCS, at a dose that did not induce changes in freezing per se, reversed the effect of IL- 1b on contextual fear memory;no change;47;89;0,919701762;0,783119369;0,585619465;6,337780899;55,155;0,262258097;;;;;;;;;0,14;-3,61;0,845200676;0,465843185;0,598373186;0,066187007;0,154681378;0,321847795
94;vehicle;0.2ug NE DH;norepinephrine in dorsal hipp;9,45;8,06;1,79;3,26;8;8;5,062884553;9,220672427;FALSCH;NS;7,438198707;-0,186873201;-14,70899471;but groups receiving (0.2 or 5ug or veh) did not differ from each other significantly;did not differ significantly;48;52;0,212752453;0,157128523;0,116618694;14,70899471;8,755;0,84959437;;;;;;;;;0,64;-1,39;0,99998816;0,97357476;0,99576262;0,068522551;0,170075046;0,359622486
95;vehicle;2.0ug NE DH;norepinephrine in dorsal hipp;9,45;28,52;1,79;8,87;8;9;5,062884553;26,61;WAHR;<0.01;19,73856867;0,966128817;201,7989418;2.0 ug NE infused into the DH immediately after training significantly enhanced freezing in comparison with infusion of vehicle;significantly enhanced;48;52;0,273862636;0,197935559;0,141987738;66,86535764;19,54588235;1,009858154;;;;;;;;;1,07;19,07;0,66971383;0,326900582;0,428994352;0,069623506;0,177333566;0,377076217
96;vehicle;5.0 ug NE DH;norepinephrine in dorsal hipp;9,45;7,5;1,79;3,62;8;8;5,062884553;10,23890619;FALSCH;NS;8,076756775;-0,241433542;-20,63492063;but groups receiving (0.2 or 5ug or veh) did not differ from each other significantly;did not differ significantly;48;52;0,187498394;0,140447922;0,106281736;20,63492063;8,475;0,953009649;;;;;;;;;0,64;-1,95;0,999907206;0,948249221;0,988379708;0,068522551;0,170075046;0,359622486
97;vehicle;0.2ug NE mPFC;norepinephrine in mPFC;35,35;50,11;4,37;7,56;16;10;17,48;23,90681911;FALSCH;NS;20,1319398;0,733163329;41,75388967;the NE 0.2 group (...) did not differ significantly from the veh group;did not differ significantly;49;52;0,804765;0,632651509;0,445998326;29,45519856;41,02692308;0,490700698;;;;;;;;;0,64;14,76;0,809314662;0,430834355;0,557536397;0,078643525;0,236566928;0,509849688
98;vehicle;2.0ug NE mPFC;norepinephrine in mPFC;35,35;54;4,37;8,3;16;10;17,48;26,24690458;WAHR;<0.05;21,19685118;0,879847664;52,75813296;NE 2.0 group had significantly more freezing than the Veh;significantly more;49;52;0,822510963;0,652795265;0,462965938;34,53703704;42,52307692;0,498478772;;;;;;;;;0,71;18,65;0,768199806;0,395948561;0,515564687;0,078643525;0,236566928;0,509849688
99;vehicle;5.0 ug NE mPFC;norepinephrine in mPFC;35,35;20;4,37;5,61;16;6;17,48;13,74163746;FALSCH;NS;16,62440826;-0,923341136;-43,42291372;essa comparação não é mencionada no texto;-;49;52;0,527043981;0,379858291;0,259081029;43,42291372;31,16363636;0,533455341;;;;;;;;;;-15,35;0,82416338;0,444712342;0,573882052;0,070224527;0,181295508;0,386501245
100;vehicle;corticosterone;glucocorticoid hormone;33,71;68,92;2;5,71;10;10;6,32455532;18,05660544;WAHR;<0.05;13,52850694;2,602652322;104,4497182;Animals in the CORT+saline group showed more freezing than animals in the vehicle+saline group;more freezing;50;53;0,999402875;0,988728335;0,920001476;51,08821822;51,315;0,263636499;;;;;;;;;0,61;35,21;0,967354378;0,668234511;0,80596369;0,073209713;0,200955551;0,432157628
101;control;sevo;induce neurotoxicity - P7 were treated with six hours of administration of sevoflurane;78,87;89,43;1,88;0,94;9;9;5,64;2,82;FALSCH;NS;4,458811501;2,36834412;13,38912134;In this paradigm, we failed to find any differences after one training day. These results indicate that sevoflurane has no effect, and n-3 PUFAs did not further improve LTM in the fear conditioning test.;failed to find differences;51;54;1;1;1;11,80811808;84,15;0,052986471;;;;;;;;;0,36;10,56;1;0,999999597;1;0,070863494;0,1855067;0,396438439
102;control;sevo;induce neurotoxicity - P7 were treated with six hours of administration of sevoflurane;63,15;57,26;1,87;1,31;9;9;5,61;3,93;FALSCH;NS;4,843397568;-1,216088483;-9,326999208;In this paradigm, we failed to find any differences after one training day. These results indicate that sevoflurane has no effect, and n-3 PUFAs did not further improve LTM in the fear conditioning test.;failed to find differences;52;55;1;1;1;9,326999208;60,205;0,080448427;;;;;;;;;0,36;-5,89;1;0,999994238;0,999999983;0,070863494;0,1855067;0,396438439
103;sham;Nac;lesion in nucleus accumbens;66,16;42,33;5,33;5,67;11;7;17,67761013;15,00140993;WAHR;<0.05;16,7242952;-1,424873199;-36,01874244;ANOVA shows that only the NAc-co group presented significant reduced freezing in the first test;significantly reduced;53;56;0,962058975;0,86129965;0,676164683;36,01874244;56,89277778;0,293961657;;;;;;;;;1,07;-23,83;0,812101078;0,433380018;0,560549956;0,069822416;0,178644856;0,380203704
104;sham;DMS;lesion in dorsomedial striatum;66,16;78,16;5,33;3,67;11;8;17,67761013;10,38032755;FALSCH;NS;15,1059735;0,79438773;18,13784764;essa comparação não é mencionada no texto;-;67;56;0,999105769;0,985580977;0,908140716;15,3531218;71,21263158;0,212124916;;;;;;;;;;12;0,906283953;0,541598703;0,682034888;0,071480414;0,189571341;0,405949495
105;sham;DLS;lesion in dorsolateral striatum;66,16;60,17;5,33;6,83;11;8;17,67761013;19,31815726;FALSCH;NS;18,37088073;-0,32605949;-9,053808948;essa comparação não é mencionada no texto;-;68;56;0,942733522;0,822660527;0,629135222;9,053808948;63,63789474;0,288678323;;;;;;;;;;-5,99;0,769017428;0,396598945;0,516358453;0,071480414;0,189571341;0,405949495
106;WT PN35 male;R168X PN35 male;methyl-CpG-binding protein 2 (MeCP2) mutante;80,99;66,04;3,73;4,36;;;;;WAHR;p=0.004;;;-18,45906902;Mecp2R168X/y male mice froze for a significantly smaller percentage of time on both the context (F 1,27 =10.04, P =0.004) and cued (F 1,27 =22.56, P <0.001) memory tasks;significantly smaller;54;57;;;;18,45906902;;;;;;;;;;;0,71;-14,95;;;;;;
107;WT PN35 male;R168X PN35 male;methyl-CpG-binding protein 2 (MeCP2) mutante;72,27;37,38;5,29;6,23;;;;;WAHR;p<0.001;;;-48,27729348;Mecp2R168X/y male mice froze for a significantly smaller percentage of time on both the context (F 1,27 =10.04, P =0.004) and cued (F 1,27 =22.56, P <0.001) memory tasks;significantly smaller;54;58;;;;48,27729348;;;;;;;;;;;0,71;-34,89;;;;;;
108;WT PN40 female;R168X PN40 female;methyl-CpG-binding protein 2 (MeCP2) mutante;80,55;84,56;4,62;4,32;;;;;FALSCH;p=0.77;;;4,978274364;the percent time freezing during the context (F 1,23 =0.45, P =0.51) and cued (F 1,23 =0.04, P =0.84) memory tasks 24 h after acquisition were similar between Mecp2R168X/+ females and wild-type littermates;were similar;55;82;;;;4,742194891;;;;;;;;;;;0;4,01;;;;;;
109;WT PN40 female;R168X PN40 female;methyl-CpG-binding protein 2 (MeCP2) mutante;55,24;52,46;7,71;8,95;;;;;FALSCH;p=0.84;;;-5,032585083;the percent time freezing during the context (F 1,23 =0.45, P =0.51) and cued (F 1,23 =0.04, P =0.84) memory tasks 24 h after acquisition were similar between Mecp2R168X/+ females and wild-type littermates;were similar;55;83;;;;5,032585083;;;;;;;;;;;0;-2,78;;;;;;
110;Non Sep/Han;Home Sep;maternally separated rats in home- context;11,59;4,16;3,57;1,92;19;17;15,56126923;7,916362801;FALSCH;NS;12,55746392;-0,59167998;-64,10698878;Within the post-shock 2 min period, there was no effect of group;no effect;56;59;0,243248105;0,177401457;0,129202802;64,10698878;8,081388889;1,553874475;;;;;;;;;0,21;-7,43;0,999791177;0,932722182;0,982749878;0,092022251;0,322212516;0,668707756
111;Non Sep/Han;Home Han;handled rats in home- context;11,59;5,93;3,57;2,06;19;16;15,56126923;8,24;FALSCH;NS;12,76503249;-0,443398793;-48,83520276;Within the post-shock 2 min period, there was no effect of group;no effect;56;59;0,230858757;0,169145666;0,124074435;48,83520276;9,002571429;1,41793182;;;;;;;;;0,21;-5,66;0,9995996;0,91704185;0,976339553;0,090655754;0,313644212;0,654603921
112;Non Sep/Han;Novel Sep;maternally separated rats in novel- context;11,59;16,63;3,57;4,8;19;16;15,56126923;19,2;FALSCH;NS;17,31031905;0,291155812;43,48576359;Within the post-shock 2 min period, there was no effect of group;no effect;56;59;0,252810116;0,183793531;0,133177735;30,30667468;13,894;1,245884486;;;;;;;;;0,21;5,04;0,974860574;0,693933893;0,82842994;0,090655754;0,313644212;0,654603921
113;Non Sep/Han;Novel Han;handled rats in novel- context;11,59;4,53;3,57;1,23;19;16;15,56126923;4,92;FALSCH;NS;11,96187352;-0,590208548;-60,91458154;Within the post-shock 2 min period, there was no effect of group;no effect;56;59;0,25632918;0,186150702;0,134644598;60,91458154;8,362571429;1,430406141;;;;;;;;;0,21;-7,06;0,999896049;0,946308368;0,987717902;0,090655754;0,313644212;0,654603921
114;Gfap +/+ 1y female;Gfap +/R236H 1y female;Glial fibrillary acidic protein (GFAP) mutant;28,16;16,5;5,08;2,69;10;10;16,06437051;8,506526906;WAHR;p<0.05;12,85350147;-0,90714581;-41,40625;at one year of age both female and male mutant mice showed a decrease in contextual fear conditioning and male mice froze less often when presented with the cue stimulus;decrease;57;60;0,608882249;0,445943007;0,304361027;41,40625;22,33;0,575615829;;;;;;;;;0,57;-11,66;0,979473092;0,712536283;0,844080634;0,073209713;0,200955551;0,432157628
115;Gfap +/+ 1y female;Gfap +/R236H 1y female;Glial fibrillary acidic protein (GFAP) mutant;38,99;30,93;3,29;4,49;10;10;10,4038935;14,19862669;FALSCH;NS;12,44672648;-0,647559823;-20,67196717;essa comparação não é mencionada no texto;-;57;61;0,892074241;0,741460542;0,543503553;20,67196717;34,96;0,356027645;;;;;;;;;;-8,06;0,985140207;0,739948965;0,866172234;0,073209713;0,200955551;0,432157628
116;Gfap +/+ 1y male;Gfap +/R236H 1y male;Glial fibrillary acidic protein (GFAP) mutant;24,45;12,8;3,29;2,99;10;10;10,4038935;9,455210204;WAHR;p<0.01;9,940875213;-1,171929005;-47,64826176;at one year of age both female and male mutant mice showed a decrease in contextual fear conditioning and male mice froze less often when presented with the cue stimulus;decrease;57;84;0,709067249;0,534923634;0,368848714;47,64826176;18,625;0,533738266;;;;;;;;;0,57;-11,65;0,999349661;0,903091471;0,970078967;0,073209713;0,200955551;0,432157628
117;Gfap +/+ 1y male;Gfap +/R236H 1y male;Glial fibrillary acidic protein (GFAP) mutant;43,07;35,31;3,29;3,05;10;10;10,4038935;9,644946864;WAHR;p<0.05;10,03160007;-0,773555559;-18,01718133;at one year of age both female and male mutant mice showed a decrease in contextual fear conditioning and male mice froze less often when presented with the cue stimulus;decrease;57;85;0,992295525;0,946765329;0,809484806;18,01718133;39,19;0,255973464;;;;;;;;;0,57;-7,76;0,999235233;0,89793858;0,967641607;0,073209713;0,200955551;0,432157628
118;Vehicle 5 days training;Abeta 5 days training;icv administration of aggregated amyloid- beta 5 days before training;28,97;32,9;3,44;3,1;10;10;10,87823515;9,803060747;FALSCH;NS;10,3546125;0,379541002;13,56575768;The administrationof Abeta did not induce any dramatic changes in the freezing duration as compared to the Vehicle-treated rats;did not induce dramatic changes;58;62;0,900313835;0,753369152;0,555209;11,94528875;30,935;0,334721594;;;;;;;;;1,21;3,93;0,998689549;0,878825899;0,95804573;0,073209713;0,200955551;0,432157628
119;Vehicle 11 days training;Abeta 11 days training;icv administration of aggregated amyloid- beta 11 days before training;30,21;21,68;3,53;3,7;10;10;11,16284014;11,70042734;WAHR;p<0.05;11,4347934;-0,745968878;-28,23568355;A significant decrease in freezing was observed in the group of rats tested onthe 12th day after Abeta administration;significant decrease;58;86;0,769389524;0,594624786;0,415038561;28,23568355;25,945;0,440732064;;;;;;;;;1,14;-8,53;0,994451506;0,808818613;0,916210006;0,073209713;0,200955551;0,432157628
120;Vehicle 27 days training;Abeta 27 days training;icv administration of aggregated amyloid- beta 27 days before training;33,17;27,31;4,22;4,22;10;10;13,34481173;13,34481173;FALSCH;NS;13,34481173;-0,439121969;-17,66656617;The administrationof Abeta did not induce any dramatic changes in the freezing duration as compared to the Vehicle-treated rats;did not induce dramatic changes;58;87;0,718121521;0,543536564;0,375350135;17,66656617;30,24;0,441296684;;;;;;;;;1,21;-5,86;0,970994262;0,680110821;0,816465719;0,073209713;0,200955551;0,432157628
121;CON male;KO male;deletion of NPY receptor, Y2R;40,39;35,93;9,44;4,72;5;5;21,10848171;10,55424085;FALSCH;NS;16,68772004;-0,267262394;-11,04233721;There were no effects found in the average freezing time during the context test the day after fear conditioning;no effect;59;63;0,415774147;0,296608593;0,204410555;11,04233721;38,16;0,437309225;0,17;1,36;0;0;1,31;0,22;0;0;0,21;-4,46;0,58716055;0,279012772;0,366477395;0,061532618;0,124097265;0,244141207
122;CON female;KO female;deletion of NPY receptor, Y2R;46,16;38,29;6,82;6,29;11;10;22,61938107;19,89072648;FALSCH;NS;21,37033482;-0,36826751;-17,04939341;There were no effects found in the average freezing time during the context test the day after fear conditioning;no effect;59;77;0,616694477;0,452523387;0,308979949;17,04939341;42,41238095;0,503870199;0,17;1,36;0;0;3,48;2,49;0;0;0,21;-7,87;0,692989033;0,341809692;0,448059985;0,074328778;0,208312458;0,448748668
123;SST +/+ D1;SST -/- D1;somatostatin deficient;51,99;54,3;6,95;6,95;7;7;18,38797161;18,38797161;FALSCH;NS;18,38797161;0,125625602;4,443162147;These results indicate no circadian regulation of fear memory consolidation. SST-/- mice displayed no deficits in tone or context-dependent fear response;no deficits;61;64;0,712949504;0,53860307;0,371619878;4,254143646;53,145;0,345996267;;;;;;;;;0,21;2,31;0,648451041;0,313879057;0,412183622;0,066187007;0,154681378;0,321847795
124;SST +/+ D2;SST -/- D2;somatostatin deficient;59,93;62,58;4,3;8,28;8;7;12,16223664;21,90682086;FALSCH;NS;17,35354719;0,152706531;4,421825463;These results indicate no circadian regulation of fear memory consolidation. SST-/- mice displayed no deficits in tone or context-dependent fear response;no deficits;61;65;0,888926219;0,737010507;0,539191869;4,234579738;61,16666667;0,283709218;;;;;;;;;0,21;2,65;0,726423301;0,364616797;0,476835914;0,067276248;0,161858992;0,339585243
125;SST +/+ D1;SST -/- D1;somatostatin deficient;37,87;42,19;9,63;10,3;7;7;25,47858513;27,2512385;FALSCH;NS;26,37980572;0,163761631;11,40744653;These results indicate no circadian regulation of fear memory consolidation. SST-/- mice displayed no deficits in tone or context-dependent fear response;no deficits;62;66;0,276668927;0,199828324;0,143168704;10,23939322;40,03;0,659000892;;;;;;;;;0,21;4,32;0,371575248;0,176984311;0,227787579;0,066187007;0,154681378;0,321847795
126;SST +/+ D2;SST -/- D2;somatostatin deficient;36,21;39,2;10,63;5,98;8;7;30,06618034;15,82159284;FALSCH;NS;24,54158668;0,121834013;8,257387462;These results indicate no circadian regulation of fear memory consolidation. SST-/- mice displayed no deficits in tone or context-dependent fear response;no deficits;62;67;0,291163912;0,209635522;0,149295549;7,62755102;37,60533333;0,652609205;;;;;;;;;0,21;2,99;0,441108962;0,207314962;0,269673998;0,067276248;0,161858992;0,339585243
127;Sham lesioned;NI lesioned;nucleus incertus lesion;12,15;17,47;6,99;4,39;10;8;22,10432084;12,41679508;FALSCH;NS;18,5010922;0,287550591;43,78600823;No significant difference between the percentage of freezing between sham- and NI-lesioned rats was observed;no significant difference;63;68;0,14864118;0,11491009;0,090462112;30,45220378;14,51444444;1,274667609;;;;;13,98;15,58;4,41;6,38;0,64;5,32;0,74601915;0,378874183;0,494577058;0,070603127;0,183790852;0,392399678
128;Sham lesioned;NI lesioned;nucleus incertus lesion;44,42;55,88;7,16;4,77;10;8;22,64190805;13,49159739;FALSCH;NS;19,18343426;0,597390428;25,79918955;No significant difference between the percentage of freezing between sham- and NI-lesioned rats was observed;no significant difference;64;69;0,800498697;0,62792301;0,442074996;20,50823193;49,51333333;0,387439766;;;;;13,98;15,58;4,41;6,38;0,64;11,46;0,715239277;0,356788169;0,467012634;0,070603127;0,183790852;0,392399678
129;WT;KO;k.o. 5-ht3ar -/- (receptor serotonina);44,26;43,24;4,3;3,58;18;17;18,24335495;14,76071814;FALSCH;NS;16,64604858;-0,061275803;-2,30456394;There were no significant differences in contextual freezing responses;no significant differences;65;70;0,948342302;0,833232876;0,641496952;2,30456394;43,76457143;0,380354429;;;;;;;;;0,64;-1,02;0,983302209;0,730358913;0,858577963;0,090928185;0,315356195;0,657453279
130;WT;KO;k.o. 5-ht3ar -/- (receptor serotonina);39,66;41,5;4,07;2,81;18;17;17,2675476;11,58592681;FALSCH;NS;14,78799534;0,124425249;4,639435199;There were no significant differences in (..) tone-cued freezing responses under context B;no significant differences;65;71;0,966225506;0,870619817;0,68836984;4,43373494;40,55371429;0,364652057;;;;;;;;;0,64;1,84;0,995864997;0,825694525;0,927186222;0,090928185;0,315356195;0,657453279
131;WT;KO;k.o. 5-ht3ar -/- (receptor serotonina);38,69;37,98;5,84;5,07;14;14;21,85127914;18,97020295;FALSCH;NS;20,46151265;-0,034699292;-1,835099509;There were also no significant differences in contextual freezing responses under context A;no significant differences;66;72;0,626965418;0,461256546;0,315143833;1,835099509;38,335;0,533755384;;;;;;;;;0,64;-0,71;0,845022891;0,465656471;0,598158913;0,082644895;0,262547491;0,562257408
132;WT;KO;k.o. 5-ht3ar -/- (receptor serotonina);40,08;41,47;5,8;4,53;14;14;21,70161284;16,94970796;FALSCH;NS;19,47116586;0,07138761;3,468063872;There were also no significant differences in (..) tone-cued freezing responses under context B;no significant differences;66;73;0,729865289;0,554878033;0,383990514;3,351820593;40,775;0,47752706;;;;;;;;;0,64;1,39;0,878323462;0,503610817;0,640912703;0,082644895;0,262547491;0,562257408
133;CON male;KO male;deletion of NPY receptor, Y2R;58,99;44,79;4,72;3,41;5;5;10,55424085;7,624991803;FALSCH;NS;9,206858856;-1,542328412;-24,07187659;KO mice trended toward freezing less;trended;60;78;0,996146845;0,96498168;0,849111192;24,07187659;51,89;0,177430311;0,17;1,36;0;0;1,31;0,22;0;0;1,86;-14,2;0,976795577;0,701419295;0,83479039;0,061532618;0,124097265;0,244141207
134;COM female;KO female;deletion of NPY receptor, Y2R;52,08;48,11;3,41;4,72;11;10;11,30969054;14,92595056;FALSCH;NS;13,14723705;-0,301964586;-7,622887865;KO mice trended toward freezing less;trended;60;79;0,985324362;0,921519414;0,763678121;7,622887865;50,18952381;0,261951819;0,17;1,36;0;0;3,48;2,49;0;0;1,86;-3,97;0,979604467;0,713107311;0,844552745;0,074328778;0,208312458;0,448748668
135;WT PN80;R168X;methyl-CpG-binding protein 2 (MeCP2) mutante;77,68;82,69;4,33;4,95;;;;;FALSCH;NS;;;6,44953656;perform no differently on the contextual and cued memory tasks than wild-type controls;no differently;69;82;;;;6,058773733;;;;;;;;;;;0,14;5,01;;;;;;
136;WT PN80;R168X;methyl-CpG-binding protein 2 (MeCP2) mutante;62,1;59,99;5,57;3,4;;;;;FALSCH;NS;;;-3,397745572;perform no differently on the contextual and cued memory tasks than wild-type controls;no differently;69;83;;;;3,397745572;;;;;;;;;;;0,14;-2,11;;;;;;
137;wt 3months;5xFAD 3 months;transgenic for hAPP and presenilin and exhibit the main features of human Alzheimer's pathology;84,13;78,41;3,17;3,49;;;;;FALSCH;NS;;;-6,799001545;6-month old but not 3-month old 5xFAD mice showed impaired memory function;no impaired memory function;70;91;;;;6,799001545;;;;;;;;;;;0,29;-5,72;;;;;;
138;wt 6 months;5xFAD 6months;transgenic for hAPP and presenilin and exhibit the main features of human Alzheimer's pathology;82,7;60,89;3,19;6,05;;;;;WAHR;p<0.05;;;-26,37243047;6-month old but not 3-month old 5xFAD mice showed impaired memory function;impaired memory function;71;91;;;;26,37243047;;;;;;;;;;;0,93;-21,81;;;;;;
139;wt 3months;5xFAD 3 months;transgenic for hAPP and presenilin and exhibit the main features of human Alzheimer's pathology;72,15;72,78;11,71;6,33;;;;;FALSCH;NS;;;0,873180873;6-month old but not 3-month old 5xFAD mice showed impaired memory function;no impaired memory function;72;92;;;;0,865622424;;;;;;;;;;;0,29;0,63;;;;;;
140;wt 6 months;5xFAD 6months;transgenic for hAPP and presenilin and exhibit the main features of human Alzheimer's pathology;83,49;63,81;5,4;7,94;;;;;WAHR;p<0.05;;;-23,57168523;6-month old but not 3-month old 5xFAD mice showed impaired memory function;impaired memory function;73;92;;;;23,57168523;;;;;;;;;;;0,93;-19,68;;;;;;
141;vehicle;L-KYN;kynurerine is injected to mimic the exposure to influenza levels of KYNA;34,37;32,64;10,31;5,03;10;10;32,60308268;15,90625663;FALSCH;NS;25,65121829;-0,06744319;-5,033459412;no significant differences during the context (...)sessions;no significant differences;74;93;0,277281594;0,200241801;0,14342675;5,033459412;33,505;0,765593741;;;;;;;;;0,64;-1,73;0,518327139;0,243585014;0,319078194;0,073209713;0,200955551;0,432157628
142;vehicle;L-KYN;kynurerine is injected to mimic the exposure to influenza levels of KYNA;68,19;74,01;5,53;4,27;10;10;17,48739546;13,50292561;FALSCH;NS;15,62270783;0,37253465;8,534975803;no significant differences during the (...) tone  test sessions;no significant differences;74;94;0,997984604;0,976361547;0,878840483;7,863802189;71,1;0,219728661;;;;;;;;;0,64;5,82;0,908806725;0,545400708;0,68605549;0,073209713;0,200955551;0,432157628
143;WT;KO;k.o. Doublecortin;38,39;38,19;6,02;6,02;;;;;FALSCH;NS;;;-0,520969002;both WT and KO mice exhibited equal enhanced freezing during the 30 s exposure to the tone, demonstrating normal cued memory;equal freezing;75;95;;;;0,520969002;;;;;;;;;;;0;-0,2;;;;;;
144;WT;KO;k.o. Doublecortin;33,62;27,44;4,76;4,77;;;;;FALSCH;NS;;;-18,38191553;exhibited similar enhanced freezing;similar freezing;75;96;;;;18,38191553;;;;;;;;;;;0;-6,18;;;;;;
145;WT;KO;k.o. Doublecortin;20,82;15,87;2,47;2,06;13;13;8,90571165;7,427435627;FALSCH;NS;8,199954268;-0,603661903;-23,77521614;exhibited similar enhanced freezing to the context;similar freezing;75;97;0,840156407;0,673667912;0,481011631;23,77521614;18,345;0,446985787;;;;;;;;;0;-4,95;0,999999897;0,994539733;0,999596682;0,080278796;0,247214802;0,531771458
146;WT;KO;k.o. Doublecortin;27,21;20,41;2,88;2,88;;;;;FALSCH;NS;;;-24,9908122;exhibited similar enhanced freezing to the context;similar freezing;75;98;;;;24,9908122;;;;;;;;;;;0;-6,8;;;;;;
147;WT;KO;k.o. Doublecortin;15,74;13,59;4;3,15;;;;;FALSCH;NS;;;-13,65946633;exhibited the same amount of freezing;same freezing;75;99;;;;13,65946633;;;;;;;;;;;0;-2,15;;;;;;
148;WT;KO;k.o. Doublecortin;21,32;19,16;3,36;1,46;;;;;FALSCH;NS;;;-10,13133208;exhibited the same amount of freezing;same freezing;75;100;;;;10,13133208;;;;;;;;;;;0;-2,16;;;;;;
149;WT;APP;APP transgenic;38,71;16,46;5,08;5,08;12;12;17,5976362;17,5976362;WAHR;p<0.01;17,5976362;-1,264374359;-57,47868768;APP-GFP mice were significantly impaired on this task;Significantly impaired;76;101;0,691380644;0,518407865;0,356521062;57,47868768;27,585;0,637942222;;;;;;;;;1,07;-22,25;0,893046981;0,52274665;0,661841258;0,077917485;0,231827529;0,499895874
150;WT;APP;APP transgenic;63,92;59,68;4,83;4,84;12;12;16,7316108;16,76625182;FALSCH;NS;16,74894026;-0,253150345;-6,633291615;none of the groups was significantly different;no significant difference;76;102;0,989485418;0,935788175;0,788572994;6,633291615;61,8;0,271018451;;;;;;;;;0,64;-4,24;0,920017621;0,563251794;0,704695731;0,077917485;0,231827529;0,499895874
151;Veh;THIP;δGABAa receptor–preferring agonist;56,39;41,24;5,13;4,46;;;;;WAHR;p<0.05;;;-26,86646569;showed reduced freezing scores relative to vehicle-treated controls;reduced;77;103;;;;26,86646569;;;4,88;1,5;0;0;25,54;24,78;2,81;3,19;0,57;-15,15;;;;;;
152;Veh;THIP;δGABAa receptor–preferring agonist;71,97;70,11;4,48;3,2;;;;;FALSCH;NS;;;-2,584410171;THIP did not impair auditory-cued fear memory;not impaired;77;104;;;;2,584410171;;;4,88;1,5;0;0;25,54;24,78;2,81;3,19;0,29;-1,86;;;;;;
153;Cond Veh;Cond WIN 10nmol/h;mothers changed behavior due to canabinoid agonist;37,28;62,43;7,91;5,93;8;8;22,37285856;16,77257285;FALSCH;?;19,7720004;1,272000783;67,46244635;presented increased duration of freezing behavior compared to the vehicle-treated conditioned group;increased;78;105;0,821952556;0,65214908;0,462415028;40,28511933;49,855;0,396590119;;;;;;;;;0,71;25,15;0,643412037;0,310869714;0,408277984;0,068522551;0,170075046;0,359622486
154;WT;TgNTRK3;Overexpressed NTRK3 gene;55,04;73,02;5,5;4,4;22;19;25,79728668;19,17915535;WAHR;p=0.014;22,98082813;0,7823913;32,66715116;showed a significantly higher freezing time;significantly higher;79;106;0,996223729;0,965406466;0,850134574;24,62339085;63,37219512;0,362632667;;;;;;;;;0,79;17,98;0,891969446;0,521285687;0,660258604;0,097870135;0,358313388;0,723887591
155;WT;TgNTRK3;Overexpressed NTRK3 gene;39,44;64;7,44;7,07;19;21;32,43020814;32,39881016;WAHR;p=0.023;32,41368668;0,757704615;62,27180527;also showed higher freezing time;higher;79;107;0,812402736;0,641224495;0,453168337;38,375;52,334;0,619361919;;;;;;;;;0,79;24,56;0,611073158;0,29218892;0,383865268;0,096815733;0,351875513;0,714542531
156;WT+GCV;GFAP-TK+GCV;GCV-dependent neurogenesis ablation;39,31;43,21;14,48;6,66;7;10;38,31047898;21,06076922;FALSCH;NS;29,20977097;0,133516966;9,921139659;Ablation of adult neurogenesis did not significantly affect cue conditioning;not significantly affect;80;109;0,278147896;0,200826606;0,143791758;9,025688498;41,60411765;0,702088462;;;;;;;;;0,21;3,9;0,359063356;0,171713108;0,220463438;0,06907288;0,173703395;0,368376937
157;Saline;LPS;neonatal inflamation;48,81;55,21;10,51;10,9;10;10;33,23553821;34,4688265;FALSCH;NS;33,85779822;0,189025877;13,1120672;Neither (...) contextual memory (...) was affected by neonatal LPS;not affected;83;110;0,383966001;0,273883996;0,189848367;11,59210288;52,01;0,650986314;;;;;;;;;0,21;6,4;0,330105084;0,159697441;0,203725964;0,073209713;0,200955551;0,432157628
158;CTL;SS;social stress in adolescent;93,6;83,08;1,5;4,13;12;12;5,196152423;14,30673967;WAHR;p=0.025;10,76296428;-0,977425896;-11,23931624;the SS rats froze less than did CTL rats;less freezing;84;111;1;0,999999999;0,999992633;11,23931624;88,34;0,121835683;11,11;11,11;3,12;2,78;;;;;0,43;-10,52;0,999474987;0,909510018;0,97302194;0,077917485;0,231827529;0,499895874
159;CTL;SS;social stress in adolescent;62,03;65,41;7,14;9,39;12;12;24,73368553;32,52791417;FALSCH;NS;28,89481268;0,116976014;5,448976302;There was no effect of adolescent social instability stress on memory (..) for cue.;no effect;84;112;0,716111775;0,541615153;0,373895334;5,167405595;63,72;0,453465359;11,11;11,11;3,12;2,78;;;;;0,21;3,38;0,496317821;0,232919341;0,304636342;0,077917485;0,231827529;0,499895874
160;CTL;SS;social stress in adolescent;90,01;88,41;4,13;4,13;12;12;14,30673967;14,30673967;FALSCH;NS;14,30673967;-0,111835403;-1,777580269;the SS rats (...) did not differ from CTL rats;did not differ;84;113;0,999999806;0,99992079;0,995234443;1,777580269;89,21;0,160371479;16,67;20,49;4,86;4,17;;;;;0,14;-1,6;0,976127495;0,698787022;0,83256328;0,077917485;0,231827529;0,499895874
161;CTL;SS;social stress in adolescent;74,56;81,99;7,14;6,39;12;12;24,73368553;22,13560932;FALSCH;NS;23,47062419;0,316565931;9,965128755;There was no effect of adolescent social instability stress on memory (..) for cue.;no effect;84;114;0,974185821;0,889851162;0,714890228;9,062080742;78,275;0,299848281;16,67;20,49;4,86;4,17;;;;;0,21;7,43;0,670563975;0,327432614;0,429678086;0,077917485;0,231827529;0,499895874
162;CTL;SS;social stress in adulthood;91,31;95,48;2,77;2,08;12;12;9,595561474;7,205331359;FALSCH;NS;8,485033883;0,491453547;4,566860147;found no significant difference between SS and CTL rats in either the Immediate;no significant difference;85;111;1;1;1;4,367406787;93,395;0,090851051;22,22;21,15;5,02;5,02;;;;;0,64;4,17;0,999998584;0,986894148;0,998514638;0,077917485;0,231827529;0,499895874
163;CTL;SS;social stress in adulthood;77,08;72,22;7,29;9,37;12;12;25,25330077;32,45863213;FALSCH;NS;29,07999312;-0,167125211;-6,305137519;found no significant difference between SS and CTL rats in either the Immediate;no significant difference;85;112;0,842296135;0,676262269;0,483289841;6,305137519;74,65;0,389551147;22,22;21,15;5,02;5,02;;;;;0,64;-4,86;0,491365427;0,230557937;0,301428814;0,077917485;0,231827529;0,499895874
164;CTL;SS;social stress in adulthood;97,56;86,8;1,38;6,59;12;12;4,780460229;22,82842964;FALSCH;NS;16,49227092;-0,652426828;-11,02911029;found no significant difference between SS and CTL rats in either the Immediate;no significant difference;85;113;0,999998378;0,999703335;0,989839509;11,02911029;92,18;0,178913766;29,75;24,37;7,17;6,45;;;;;0,64;-10,76;0,927519337;0,576203915;0,717972022;0,077917485;0,231827529;0,499895874
165;CTL;SS;social stress in adulthood;91,66;84,02;4,16;5,2;12;12;14,41066272;18,0133284;FALSCH;NS;16,31176263;-0,468373662;-8,335151647;found no significant difference between SS and CTL rats in either the Immediate;no significant difference;85;114;0,999992319;0,999223226;0,982398454;8,335151647;87,84;0,185698573;29,75;24,37;7,17;6,45;;;;;0,64;-7,64;0,932592447;0,585507041;0,727376885;0,077917485;0,231827529;0,499895874
166;WT;AQP4 KO;k.o. para aquaporina 4;51;29,4;4,7;4,7;15;12;18,20302173;16,28127759;WAHR;p<0.01;17,38364749;-1,242547055;-42,35294118;KO mice showed markedly decreased freezing behavior compared to that of WT mice;markedly decreased;86;115;0,932937497;0,805165615;0,609390691;42,35294118;41,4;0,419894867;;;;;;;;;1,79;-21,6;0,927539194;0,576239421;0,718008126;0,081066969;0,252332539;0,542089323
167;il1rapl1+/y;il1rapl1-/y;deletion of il1rapl1;47;29;5;5;24;19;24,49489743;21,79449472;WAHR;p<0.01;23,34784682;-0,770949036;-38,29787234;il1rapl1 -/y mice exhibited a lower fear response than their WT littermates;lower;87;116;0,849099242;0,684609094;0,490675033;38,29787234;39,04651163;0,597949621;8,54;2,09;0;0;11,12;3,22;0;0;0,5;-18;0,894239365;0,524375409;0,663602701;0,099833833;0,370215013;0,740609756
168;il1rapl1+/y;il1rapl1-/y;deletion of il1rapl1;75;73;5;5;12;12;17,32050808;17,32050808;FALSCH;NS;17,32050808;-0,115470054;-2,666666667;il1rapl1 KO mice did not exhibit any deficit (..) during the recall test;no deficit;87;117;0,998023886;0,976642436;0,879647615;2,666666667;74;0,23406092;;;;;16,63;7,04;4;3,36;0,21;-2;0,902191804;0,535581489;0,675635872;0,077917485;0,231827529;0,499895874
169;Veh (20% hydroxyl-propyl betacyclodextrin (HPBCD) in sterile water);DPFE 0.1mg/kg;mGlu5 positive allosteric modulators;22,45;34,03;4,56;5,26;;;;;FALSCH;NS;;;51,58129176;pretreatment with DPFE (0.1–0.56 mg/kg i.p.) produced dose-related enhancement in the acquisition of contextual fear conditioning, significant at the 0.56 mg/kg dose;enhancement;88;118;;;;34,02879812;;;;;;;;;;;1,14;11,58;;;;;;
170;Veh (20% hydroxyl-propyl betacyclodextrin (HPBCD) in sterile water);DPFE 0.3mg/kg;mGlu5 positive allosteric modulators;22,45;44,21;4,56;8,07;;;;;FALSCH;NS;;;96,92650334;pretreatment with DPFE (0.1–0.56 mg/kg i.p.) produced dose-related enhancement in the acquisition of contextual fear conditioning, significant at the 0.56 mg/kg dose;enhancement;88;118;;;;49,21963357;;;;;;;;;;;1,14;21,76;;;;;;
171;Veh (20% hydroxyl-propyl betacyclodextrin (HPBCD) in sterile water);DPFE 0.56mg/kg;mGlu5 positive allosteric modulators;22,45;56,49;4,56;8,77;;;;;WAHR;p<0.01;;;151,6258352;pretreatment with DPFE (0.1–0.56 mg/kg i.p.) produced dose-related enhancement in the acquisition of contextual fear conditioning, significant at the 0.56 mg/kg dose;significant enhancement;88;118;;;;60,25845282;;;;;;;;;;;1,21;34,04;;;;;;
172;SHAM;OBX veh;olfactory bulbs removed;87,43;42,14;2,35;5,23;;;;;WAHR;p<0.001;;;-51,80144115;vehicle-treated OBX mice were markedly decreased compared with those of the footshocked sham;markedly decreased;89;119;;;;51,80144115;;;;;;;;;;;1,79;-45,29;;;;;;
173;SHAM;OBX veh;olfactory bulbs removed;75,39;30,1;5,49;9,68;;;;;WAHR;p<0.001;;;-60,07428041;vehicle-treated OBX mice were markedly decreased compared with those of the footshocked sham;markedly decreased;89;120;;;;60,07428041;;;;;;;;;;;1,79;-45,29;;;;;;
174;WT;mGlu4 -/-;k.o. para mGlu4;26,75;15,39;7,2;3,6;10;10;22,76839915;11,38419958;FALSCH;NS;18;-0,631111111;-42,46728972;essa comparação não é mencionada no texto;-;90;121;0,329138726;0,235597181;0,165586649;42,46728972;21,07;0,854295206;;;;;;;;;;-11,36;0,815534872;0,436553356;0,564297002;0,073209713;0,200955551;0,432157628
175;WT;mGlu8 -/-;k.o. para mGlu8;26,75;8,67;7,2;2,31;10;8;22,76839915;6,533666658;FALSCH;p=0.061;17,61466293;-1,026417597;-67,58878505;showed trends towards less freezing;trends of less freezing;90;121;0,309390129;0,222044957;0,157068524;67,58878505;18,71444444;0,941233547;;;;;;;;;1,86;-18,08;0,786390147;0,410808397;0,533594644;0,070603127;0,183790852;0,392399678
176;WT;mGlu4/8 -/-;k.o. para mGlu4 e mGlu8;26,75;6,59;7,2;2,32;10;6;22,76839915;5,682816203;FALSCH;p=0.052;18,56854483;-1,085707048;-75,36448598;showed trends towards less freezing;trends of less freezing;90;121;0,246824883;0,179790334;0,130687866;75,36448598;19,19;0,967615676;;;;;;;;;1,86;-20,16;0,669937214;0,327040291;0,429173921;0,067354096;0,162372117;0,340845124
177;WT;mGlu4 -/-;k.o. para mGlu4;29,71;34,06;4,37;6,69;13;8;15,75625907;18,92217746;FALSCH;NS;16,99141889;0,25601158;14,64153484;essa comparação não é mencionada no texto;-;90;122;0,530495517;0,382551009;0,26088988;12,77157957;31,36714286;0,541694823;;;;;;;;;;4,35;0,853988859;0,475265196;0,609135833;0,072986039;0,199484036;0,428806236
178;WT;mGlu8 -/-;k.o. para mGlu8;29,71;28,11;4,37;2,83;13;8;15,75625907;8,004448763;FALSCH;NS;13,43133571;-0,119124414;-5,385392124;essa comparação não é mencionada no texto;-;90;122;0,613026379;0,449427114;0,306803909;5,385392124;29,10047619;0,461550375;;;;;;;;;;-1,6;0,968022148;0,670341064;0,807841331;0,072986039;0,199484036;0,428806236
179;WT;mGlu4/8 -/-;k.o. para mGlu4 e mGlu8;29,71;10,06;4,37;2,57;13;9;15,75625907;7,71;WAHR;p=0.011;13,1428102;-1,495114036;-66,13934702;showed less freezing (..) than wild-type;less freezing;90;122;0,662697155;0,492417803;0,337470164;66,13934702;21,67136364;0,60645977;;;;;;;;;0,43;-19,65;0,981122846;0,719902047;0,850131942;0,074705451;0,21078657;0,454266036
180;WT;mGlu4 -/-;k.o. para mGlu4;38,27;26,91;8,14;8,64;10;10;25,74094015;27,32207898;FALSCH;NS;26,5432854;-0,427980178;-29,68382545;there was no effect of genotype on cued freezing in female or male mice;no effect;90;123;0,312993676;0,224509327;0,158615099;29,68382545;32,59;0,814461043;;;;;;;;;0,21;-11,36;0,491452608;0,230599388;0,301485149;0,073209713;0,200955551;0,432157628
181;WT;mGlu8 -/-;k.o. para mGlu8;38,27;15,8;8,14;2,96;10;8;25,74094015;8,372144289;FALSCH;NS;20,08421893;-1,11878884;-58,7143977;there was no effect of genotype on cued freezing in female or male mice;no effect;90;123;0,449877037;0,321455565;0,220494238;58,7143977;28,28333333;0,710107917;;;;;;;;;0,21;-22,47;0,675570967;0,33058472;0,433723888;0,070603127;0,183790852;0,392399678
182;WT;mGlu4/8 -/-;k.o. para mGlu4 e mGlu8;38,27;27,4;8,14;7,4;10;6;25,74094015;18,1262241;FALSCH;NS;23,30874146;-0,466348645;-28,40344918;there was no effect of genotype on cued freezing in female or male mice;no effect;90;123;0,305862565;0,219636107;0,155557767;28,40344918;34,19375;0,681666722;;;;;;;;;0,21;-10,87;0,48079591;0,225563096;0,294632559;0,067354096;0,162372117;0,340845124
183;WT;mGlu4 -/-;k.o. para mGlu4;39,25;37,77;7,65;10,86;13;8;27,58246726;30,71671857;FALSCH;NS;28,77693484;-0,051430078;-3,770700637;there was no effect of genotype on cued freezing in female or male mice;no effect;90;124;0,283276771;0,204292646;0,145956042;3,770700637;38,68619048;0,743855481;;;;;;;;;0,21;-1,48;0,428456028;0,201651476;0,261888838;0,072986039;0,199484036;0,428806236
184;WT;mGlu8 -/-;k.o. para mGlu8;39,25;42,46;7,65;9,38;13;8;27,58246726;26,53064643;FALSCH;NS;27,19968692;0,118016064;8,178343949;there was no effect of genotype on cued freezing in female or male mice;no effect;90;124;0,354357875;0,253079776;0,176626282;7,560056524;40,47285714;0,67204761;;;;;;;;;0,21;3,21;0,469230771;0,220165294;0,287270538;0,072986039;0,199484036;0,428806236
185;WT;mGlu4/8 -/-;k.o. para mGlu4 e mGlu8;39,25;35,8;7,65;7,9;13;9;27,58246726;23,7;FALSCH;NS;26,09887929;-0,132189584;-8,789808917;there was no effect of genotype on cued freezing in female or male mice;no effect;90;124;0,353378122;0,252396664;0,176193756;8,789808917;37,83863636;0,689741539;;;;;;;;;0,21;-3,45;0,529216461;0,248970901;0,326341872;0,074705451;0,21078657;0,454266036
186;Veh (saline);OXY-BLA;synthetic oxytocin;75,74;92,76;3,83;2,55;14;9;14,33054779;7,65;WAHR;p<0.05;12,22394177;1,392349565;22,47161341;drug-treated groups were significantly different from the vehicle-treated group and expressed high freezing levels;significantly different;91;125;1;0,99999836;0,999493114;18,34842605;82,4;0,148348808;;;;;;;;;0,86;17,02;0,992774555;0,792320671;0,904972172;0,075458745;0,215730707;0,465196835
187;Veh (saline);WAY-BLA;selective non-peptide oxytocin agonist;75,74;83,82;3,83;6,8;14;8;14,33054779;19,23330445;WAHR;P<0.05;16,2160103;0,498272994;10,66807499;drug-treated groups were significantly different from the vehicle-treated group and expressed high freezing levels;significantly different;91;125;0,999616012;0,991392453;0,931256611;9,639704128;78,67818182;0,206105555;;;;;;;;;0,86;8,08;0,892819042;0,522436745;0,66150575;0,073636855;0,20376473;0,43852525
188;Veh (saline);TGOT-BLA;selective oxytocin receptor agonist;75,74;85,1;3,83;4,25;14;9;14,33054779;12,75;WAHR;P<0.05;13,74987411;0,680733505;12,35806707;drug-treated groups were significantly different from the vehicle-treated group and expressed high freezing levels;significantly different;91;125;0,999998364;0,999701771;0,989808905;10,99882491;79,4026087;0,173166529;;;;;;;;;0,86;9,36;0,974820792;0,693784308;0,828301982;0,075458745;0,215730707;0,465196835
189;Veh (saline);OXY-CEA;synthetic oxytocin;75,32;85,37;4,44;6,52;11;7;14,72581407;17,25029855;FALSCH;NS;15,72007634;0,639309873;13,34306957;essa comparação não é mencionada no texto;-;92;125;0,999231156;0,986849394;0,912766483;11,77228535;79,22833333;0,198414831;;;;;;;;;;10,05;0,85711481;0,478711918;0,613048312;0,069822416;0,178644856;0,380203704
190;Veh (saline);WAY-CEA;selective non-peptide oxytocin agonist;75,32;40,83;4,44;6,82;11;9;14,72581407;20,46;WAHR;P<0.001;17,50775828;-1,969983789;-45,79129049;WAY and TGOT-treated groups were significantly different from the vehicle;significantly different;92;125;0,992011698;0,945590605;0,807159262;45,79129049;59,7995;0,292774326;;;;;;;;;0,86;-34,49;0,832505669;0,452869434;0,58339369;0,072974857;0,19941046;0,42863838
191;Veh (saline);TGOT-CEA;selective oxytocin receptor agonist;75,32;55,03;4,44;10,38;11;9;14,72581407;31,14;WAHR;P<0.001;23,48296404;-0,864030621;-26,93839618;WAY and TGOT-treated groups were significantly different from the vehicle;significantly different;92;125;0,902797769;0,757038079;0,558866315;26,93839618;66,1895;0,354783826;;;;;;;;;0,86;-20,29;0,58711499;0,27898814;0,366444763;0,072974857;0,19941046;0,42863838
195;NS-GFP;STR-GFP;immobilization stress;71,19;34,43;6,29;6,62;9;7;18,87;17,51487368;WAHR;p<0,05;18,30152218;-2,008576097;-51,6364658;STR-GFP group showed lower levels of conditional freezing than rats in the NS-GFP;lower;93;126;0,941044905;0,819561879;0,625575895;51,6364658;55,1075;0,332105833;3,05;3,05;0;0;35,34;28,17;8,5;7,7;0,5;-36,76;0,703630425;0,348878808;0,457030285;0,06823031;0,168148321;0,35494991
196;NS-GFP;STR-GFP;immobilization stress;81,04;45,36;4,96;11,58;9;7;14,88;30,63780018;WAHR;p<0,05;22,99590647;-1,551580498;-44,02764067;STR-GFP group showed lower levels of conditional freezing than rats in the NS-GFP;lower;93;127;0,891083209;0,740053911;0,542137077;44,02764067;65,43;0,351458146;3,05;3,05;0;0;35,34;28,17;8,5;7,7;0,5;-35,68;0,510237917;0,239631654;0,313733953;0,06823031;0,168148321;0,35494991
197;NS-GFP;STR-GFP;immobilization stress;86,97;44,98;8,17;20,58;4;4;16,34;41,16;WAHR;p<0,05;31,31406393;-1,34093103;-48,28101644;essa comparação não é mencionada no texto;-;94;128;0,43379554;0,30967284;0,212844887;48,28101644;65,975;0,4746353;5,27;1,48;0;0;45,72;28,99;9,02;11,1;;-41,99;0,179936167;0,100320281;0,120453892;0,059214026;0,108954618;0,204663631
198;Tone;Tone/shock/light;optogenetic activation of BLA neurons;45,07;11,51;8,07;3,35;7;8;21,35121308;9,475230868;WAHR;p=0.001;16,08560226;-2,086337798;-74,46194808;displayed significantly less freezing in response to CS presentation compared with mice receiving sham stimulation;significantly less;95;129;0,695474533;0,522195756;0,359332654;74,46194808;27,17133333;0,592006364;;;;;;;;;0,79;-33,56;0,789294026;0,413260363;0,536548237;0,067276248;0,161858992;0,339585243
199;regular diet;intermittent fasting;redução do consumo energético/jejum;49,46;63,12;9,28;9,5;;;;;WAHR;p<0.05;;;27,6182774;also had increased context-related freezing behavior;increased;96;130;;;;21,64131812;;;;;;;;;;;0,71;13,66;;;;;;
200;regular diet;high fat diet;aumento do consumo de gordura;49,46;60,43;9,28;5,08;;;;;FALSCH;p>0.05;;;22,17953902;High fat feeding did not affect the performance;did not affect;96;130;;;;18,15323515;;;;;;;;;;;0,21;10,97;;;;;;
201;regular diet;intermittent fasting;redução do consumo energético/jejum;23,45;34,68;15,68;15,02;;;;;FALSCH;p>0.05;;;47,8891258;essa comparação não é mencionada no texto;-;96;131;;;;32,38177624;;;;;;;;;;;;11,23;;;;;;
202;regular diet;high fat diet;aumento do consumo de gordura;23,45;22,7;15,68;3,97;;;;;FALSCH;p>0.05;;;-3,198294243;High fat feeding did not affect the performance;did not affect;96;131;;;;3,198294243;;;;;;;;;;;0,21;-0,75;;;;;;
203;NT 6months;A line 6 months;VCPA232E overexpressing;39,93;33,87;2,88;3,68;12;12;9,976612652;12,74789394;FALSCH;p>0.05;11,44643176;-0,52942263;-15,17655898;essa comparação não é mencionada no texto;-;97;132;0,973856508;0,889011331;0,713690172;15,17655898;36,9;0,310201403;;;;;;;;;;-6,06;0,998482064;0,87303132;0,954970494;0,077917485;0,231827529;0,499895874
204;NT 6months;B line 6 months;VCPA232E overexpressing (higher expressing);39,93;27,98;2,88;3,04;12;11;9,976612652;10,08253936;WAHR;p<0.05;10,0271935;-1,191759189;-29,9273729;only the higher-expressing B line showed impairments at 6 and 12 months of age;impairments;97;132;0,99168963;0,944277747;0,804586925;29,9273729;34,21478261;0,293066118;;;;;;;;;0,93;-11,95;0,999798012;0,933440658;0,983026743;0,076687438;0,22378312;0,482726232
205;NT 12months;A line 12months;VCPA232E overexpressing;39,24;32,06;2,24;2,72;12;10;7,759587618;8,601395236;FALSCH;p>0.05;8,149169283;-0,881071401;-18,29765545;essa comparação não é mencionada no texto;-;97;132;0,999247708;0,98702274;0,91341381;18,29765545;35,97636364;0,226514535;;;;;;;;;;-7,18;0,999998211;0,985838098;0,998332523;0,075347113;0,214998359;0,463585727
206;NT 12months;B line 12months;VCPA232E overexpressing (higher expressing);39,24;27,45;2,24;3,52;12;12;7,759587618;12,19363769;WAHR;p<0.05;10,21998043;-1,153622561;-30,04587156;only the higher-expressing B line showed impairments at 6 and 12 months of age;impairments;97;132;0,990185806;0,938400425;0,79339268;30,04587156;33,345;0,306492141;;;;;;;;;0,93;-11,79;0,999811006;0,934853766;0,983566805;0,077917485;0,231827529;0,499895874
207;Veh (saline);SR-8993;NOP-R selective agonist;35,22;25,64;8,5;4,34;8;8;24,04163056;12,27537372;WAHR;p<0.01;19,08775524;-0,501892437;-27,20045429;SR-8993 impaired cued-fear memory consolidation when injected 30 min;impaired;98;133;0,391664839;0,279347044;0,193337178;27,20045429;30,43;0,627267671;0,81;4,61;0;0;13,98;15,47;5,29;7,46;0,93;-9,58;0,67401348;0,329600773;0,432461904;0,068522551;0,170075046;0,359622486
208;Veh (saline);SR-8993;NOP-R selective agonist;39,92;21,19;6,83;4,8;;;;;WAHR;p<0.05;;;-46,91883768;SR-8993 dosing immediately after fear conditioning caused impaired cued-fear memory consolidation;impaired;98;134;;;;46,91883768;;;0,49;1,68;0;0;5,74;7,62;4,26;3,56;0,93;-18,73;;;;;;
209;Veh (saline);SR-8993;NOP-R selective agonist;33,6;22,72;4;4,16;6;6;9,797958971;10,18987733;WAHR;p<0.05;9,995839134;-1,088452891;-32,38095238;also impaired cued-fear memory consolidation;impaired;99;134;0,7573604;0,582251104;0,405238518;32,38095238;28,16;0,354965878;0,18;0,18;0;0;3,92;3,92;0;0;0,93;-10,88;0,978676152;0,709126163;0,841250849;0,063856988;0,1393477;0,283285026
210;CK, PEG;CK-p25, PEG;overexpression of neurofibrilary tangles;61,63;32,75;3,01;4,31;7;9;7,963711446;12,93;WAHR;p<0.001;11,07765898;-2,60704902;-46,86029531;CK-p25 mice treated with ehicle showed a 48% decrease in their learning abilities in contextual ear conditioning compared with control;decrease;100;135;0,998963698;0,984225941;0,90339521;46,86029531;45,385;0,244081943;;;;;;;;;0,57;-28,88;0,984681662;0,737481959;0,864232633;0,06823031;0,168148321;0,35494991
211;Control virus;Trial;Silencing PL mPFC;59,01;22,61;12,36;10,6;7;4;32,7014862;21,2;WAHR;p<0.05;29,37240428;-1,239258443;-61,68446026;The Control Virus group showed (...) significantly greater freezing than the Trial (...);significantly greater;102;136;0,309994195;0,222457804;0,157327545;61,68446026;45,77363636;0,641688243;;;;;;;;;1,14;-36,4;0,239482515;0,123425383;0,152926244;0,061743688;0,125479592;0,247717549
212;Control virus;Trace Interval;Silencing PL mPFC;59,01;23,67;12,36;5,3;7;6;32,7014862;12,98229564;WAHR;p<0.05;25,68873683;-1,375700185;-59,88815455;The Control Virus group showed (...) significantly greater freezing than the (...) Trace Interval;significantly greater;102;136;0,470122025;0,33646691;0,230301486;59,88815455;42,69923077;0,6016206;;;;;;;;;1,14;-35,34;0,363362714;0,173518704;0,222973584;0,064931687;0,146415875;0,301168853
213;Control virus;Trial;Silencing PL mPFC;53,52;71,47;9,15;8,09;7;4;24,2086245;16,18;FALSCH;p>0.05;21,86250519;0,8210404;33,53886398;essa comparação não é mencionada no texto;-;103;137;0,663118516;0,492792974;0,337742284;25,11543305;60,04727273;0,364088229;;;;;;;;;;17,95;0,389577946;0,184661115;0,238432141;0,061743688;0,125479592;0,247717549
214;Control virus;Trace Interval;Silencing PL mPFC;53,52;72,88;9,15;9,15;7;6;24,2086245;22,41283115;FALSCH;p>0.05;23,40943866;0,827016841;36,17339312;silencing PL during the trace interval did not interfere with the contextual association;did not interfere;103;137;0,723936584;0,549127786;0,37959828;26,56421515;62,45538462;0,374818581;;;;;;;;;0,21;19,36;0,42349824;0,199451147;0,258859494;0,064931687;0,146415875;0,301168853
215;Non-tg;TG-2576;alzheimer's disease mice (APP swedish mutations);82,09;38,85;7,77;7,43;16;16;31,08;29,72;WAHR;p<0.05;30,40760431;-1,422012716;-52,67389451;essa comparação não é mencionada no texto;-;104;138;0,936466034;0,811337942;0,616261298;52,67389451;60,47;0,502854379;;;;;;;;;;-43,24;0,571585439;0,270690698;0,355425964;0,087390985;0,292988936;0,618982436
216;Control;MgT;Magnesium-L-threonate, elevate brain magnesium;42,1;36,57;11,05;9,73;10;12;34,94316814;33,70570872;FALSCH;p=0.69;34,2680958;-0,161374593;-13,13539192;showed equivalent freezing behavior during a 5min LTM test;equivalent;105;139;0,25833831;0,187497654;0,135483071;13,13539192;39,08363636;0,87678883;;;;;;;;;0;-5,53;0,347831494;0,167023246;0,213937298;0,075347113;0,214998359;0,463585727
217;Shmt+/+;Shmt+/-;Shmt k.o.;30,24;16,69;3,87;2,41;;;;;WAHR;p=0.02;;;-44,80820106;Shmt1+/2 mice froze signiﬁcantly less compared with Shmt1+/+ mice during presentation of the tone alone;significantly less;106;140;;;;44,80820106;;;3,68;2,84;1,05;0,95;;;;;0,79;-13,55;;;;;;
218;Shmt+/+;Shmt-/-;Shmt k.o.;30,24;21,29;3,87;4,59;;;;;FALSCH;p>0.05;;;-29,59656085;essa comparação não é mencionada no texto;-;106;140;;;;29,59656085;;;3,68;3,05;1,05;0,95;;;;;;-8,95;;;;;;
219;Shmt+/+;Shmt+/-;Shmt k.o.;67,06;67,06;2,27;2,27;;;;;FALSCH;p>0.1;;;0;freezing behavior during the context test did not differ among groups;did not differ;106;141;;;;0;;;3,68;2,84;1,05;0,95;;;;;0,14;0;;;;;;
220;Shmt+/+;Shmt-/-;Shmt k.o.;67,06;71,41;2,27;3,2;;;;;FALSCH;p>0.1;;;6,486728303;freezing behavior during the context test did not differ among groups;did not differ;106;141;;;;6,091583812;;;3,68;3,05;1,05;0,95;;;;;0,14;4,35;;;;;;
221;Veh (saline);Ro25;antagonista NMDA, seletivo NR2B;46,4;33,98;8,49;7,51;12;11;29,41022271;24,90785218;FALSCH;p>0,05;27,35880132;-0,453967257;-26,76724138;NR2B antagonist Ro25 impaired CS but not contextual memory in trace rats;not impaired;107;142;0,458170102;0,327580072;0,22448692;26,76724138;40,46;0,676193804;19,81;14,81;6,72;4,14;;;;;0,29;-12,42;0,521920361;0,245353971;0,321466088;0,076687438;0,22378312;0,482726232
222;Veh (saline);NVP;antagonista NMDA, seletivo NR2A;46,4;15,03;8,49;5,55;12;6;29,41022271;13,59466807;WAHR;p<0.05;25,54242574;-1,228152734;-67,60775862;NVP rats also froze signiﬁcantly less than controls during the context test;significantly less;107;142;0,381694731;0,272276674;0,188823278;67,60775862;35,94333333;0,710630411;19,81;9,12;6,72;1,89;;;;;0,79;-31,37;0,437212047;0,20556321;0,267267893;0,068522551;0,170075046;0,359622486
223;Veh (saline);Ro25;antagonista NMDA, seletivo NR2B;46,95;27,82;6,66;6,66;12;11;23,07091676;22,0887211;WAHR;p<0.05;22,60852684;-0,846140933;-40,74547391;Ro25 impaired Cs but not contextual memory in trace rats;impaired;108;143;0,622144941;0,457146026;0,312237742;40,74547391;37,80086957;0,598095417;19,81;14,81;6,72;4,14;;;;;0,93;-19,13;0,683760497;0,335810939;0,440412568;0,076687438;0,22378312;0,482726232
224;Veh (saline);NVP;antagonista NMDA, seletivo NR2A;46,95;13,91;6,66;3,18;12;6;23,07091676;7,789377382;WAHR;p<0,05;19,61872702;-1,68410519;-70,37273695;NVP rats froze signiﬁcantly less during the CS compared with controls;significantly less;108;143;0,589010272;0,429434898;0,292866609;70,37273695;35,93666667;0,545925063;19,81;9,12;6,72;1,89;;;;;0,79;-33,04;0,650168875;0,314911445;0,41352173;0,068522551;0,170075046;0,359622486
225;Veh (saline);Ro25;antagonista NMDA, seletivo NR2B;52,9;61,33;7,84;8,72;11;11;26,00233836;28,92096817;FALSCH;p>0.05;27,5004;0,306540996;15,93572779;Ro25 in PL had no effect on delay fear conditioning to the CS;no effect;108;144;0,665537825;0,494950759;0,339308969;13,74531225;57,115;0,481491727;3,75;2,95;0;0;;;;;0,21;8,43;0,500964172;0,235147373;0,307659405;0,075561084;0,216401986;0,46667114
226;Veh (saline);NVP;antagonista NMDA, seletivo NR2A;52,9;25;7,84;6,39;11;6;26,00233836;15,65223946;WAHR;p<0,05;23,07405325;-1,209150369;-52,74102079;NVP impaired CS memory in delay rats;impaired;108;144;0,540723982;0,390575625;0,266297463;52,74102079;43,05294118;0,535946038;3,75;4,5;0;0;;;;;0,93;-27,9;0,502012174;0,235651619;0,308343134;0,067972521;0,166448794;0,350814815
227;Veh (saline);Ro25;antagonista NMDA, seletivo NR2B;13,02;32,24;4,23;7,81;11;11;14,02932286;25,90283961;WAHR;p<0,05;20,8300144;0,922706995;147,6190476;Ro25 rats showed increased contextual freezing relative to controls;increased;107;145;0,38111507;0,271866775;0,18856196;59,61538462;22,63;0,920460203;;;;;;;;;0,71;19,22;0,735879069;0,371406691;0,485309086;0,075561084;0,216401986;0,46667114
228;Veh (saline);NVP;antagonista NMDA, seletivo NR2A;13,02;7,49;4,23;2,93;11;6;14,02932286;7,177004946;FALSCH;p>0.05;12,18131356;-0,453974029;-42,47311828;NVP rats exhibited less freezing than controls, but a potential ﬂoor effect may have obscured an impairment;less freezing;107;145;0,16074603;0,122853968;0,095384083;42,47311828;11,06823529;1,100565107;;;;;;;;;1,79;-5,53;0,960963792;0,64946084;0,788951331;0,067972521;0,166448794;0,350814815
229;mGlu-7 +/+;mGlu-7 -/-;ablation of glutamate receptor (mGlu-7);74,6;40;4,49;6,29;;;;;WAHR;p<0,01;;;-46,38069705;was significantly reduced in mGlu7-deficient mice on day 2;significantly reduced;109;146;;;;46,38069705;;;6,3;4,12;0;0;11,87;31,27;3,27;6,78;1,07;-34,6;;;;;;
230;mGlu-8 +/+;mGlu-8 -/-;ablation of glutamate receptor (mGlu-8);64,36;39,99;5,97;5,97;;;;;WAHR;p<0.01;;;-37,86513362;mGlu8-deficient mice showed an impaired freezing response when tested for the retention of contextual fear memory;impaired;109;146;;;;37,86513362;;;0;1,21;0;0;0,73;1,58;0;0;0,93;-24,37;;;;;;
231;F-S-0.25 (saline);F-T-0.25;inactivation of the FF area (TTX);62,33;55,51;3,57;3,89;11;12;11,8403505;13,47535528;FALSCH;NS;12,7230129;-0,536036555;-10,94176159;but not treatments [F(1,42) = 1.16, N.S.] were statistically significant.;not statistically significant;110;147;0,999660157;0,992011718;0,934085868;10,94176159;58,77173913;0,216481817;;;;;;;;;0,71;-6,82;0,991169434;0,778875016;0,895455243;0,076687438;0,22378312;0,482726232
232;F-S-0.25 (saline);F-T-0.25;inactivation of the FF area (TTX);85,01;93,48;3,9;3,9;11;12;12,93483668;13,5099963;FALSCH;NS;13,23922743;0,639765428;9,963533702;but not treatments [F(1,42) = 1.16, N.S.] were statistically significant.;not statistically significant;110;148;0,999999996;0,999992797;0,998804515;9,06076166;89,42913043;0,148041554;;;;;;;;;0,71;8,47;0,986227731;0,746020694;0,870904256;0,076687438;0,22378312;0,482726232
233;E-S-0.25 (saline);E-T-0.25;inactivation of the Entorhinal cortex area (TTX);59,05;29,92;3,54;3,54;;;;;WAHR;p<0.01;;;-49,33107536;both contextual and CS freezing retention were impaired;impaired;110;147;;;;49,33107536;;;;;;;;;;;0,93;-29,13;;;;;;
234;E-S-1.5 (saline);E-T-1.5;inactivation of the Entorhinal cortex area (TTX);59,44;35,03;3,15;3,54;;;;;WAHR;p<0.05;;;-41,0666218;was still followed by retention impairment of contextual freezing;impairment;110;147;;;;41,0666218;;;;;;;;;;;0,93;-24,41;;;;;;
235;E-S-0.25 (saline);E-T-0.25;inactivation of the Entorhinal cortex area (TTX);88,73;58,94;3,14;5,5;;;;;WAHR;p<0.05;;;-33,5737631;both contextual and CS freezing retention were impaired;impaired;110;148;;;;33,5737631;;;;;;;;;;;0,93;-29,79;;;;;;
236;E-S-1.5 (saline);E-T-1.5;inactivation of the Entorhinal cortex area (TTX);89,18;92,87;3,53;3,13;;;;;FALSCH;NS;;;4,137699036;but there was no retention impairment of acoustic CS response;no impairment;110;148;;;;3,973296005;;;;;;;;;;;0,29;3,69;;;;;;
239;SHAM + vehicle;TBI + vehicle;traumatic brain injury;34,35;13,49;6,28;3,98;8;8;17,76252234;11,25713996;WAHR;p=0.013;14,86994284;-1,402829871;-60,72780204;Both cue and contextual fear conditioning were significantly decreased in TBI animals;significantly decreased;112;149;0,5592833;0,405314164;0,276297812;60,72780204;23,92;0,621653129;8,22;5,69;1,68;1,37;;;;;1,14;-20,86;0,871785257;0,495631717;0,632060303;0,068522551;0,170075046;0,359622486
240;SHAM + vehicle;TBI + vehicle;traumatic brain injury;41,25;23,77;5,06;3,22;8;8;14,31184125;9,107535342;WAHR;p=0.011;11,99533243;-1,457233479;-42,37575758;Both cue and contextual fear conditioning were significantly decreased in TBI animals;significantly decreased;112;150;0,880939345;0,725948027;0,528612984;42,37575758;32,51;0,368973621;8,22;5,69;1,68;1,37;;;;;1,14;-17,48;0,969708615;0,675802331;0,81267938;0,068522551;0,170075046;0,359622486
241;No Shock conditoned;15 Shocks conditoned;previous stress protocol;28,57;51,35;3,08;7,33;9;10;9,24;23,17949525;WAHR;p<0.01;18,01734752;1,264337049;79,7339867;there was a significant main effect of stress exposure;significant effect;113;151;0,808302543;0,636604699;0,449295359;44,36222006;40,55947368;0,444220447;9,72;22,43;2,62;5,23;;;;;1;22,78;0,793767199;0,417083404;0,541141139;0,071974211;0,192823661;0,41350208
242;No Shock conditoned;15 Shocks conditoned;previous stress protocol;50,19;79,53;5,79;5,01;6;5;14,18254561;11,20270057;WAHR;p<0.01;12,9431449;2,266837018;58,45786013;there was a significant main effect of stress exposure;significant effect;114;152;0,996233688;0,96546174;0,850268152;36,89173897;63,52636364;0,203744464;13,46;22,43;4,49;6,35;;;;;1;29,34;0,83545212;0,45581792;0,58681412;0,062588441;0,131017424;0,261991073
243;No Shock conditoned;15 Shocks conditoned;previous stress protocol;33,59;61,39;5,79;4,24;5;8;12,94683359;11,99253101;WAHR;p<0.05;12,34808634;2,251360998;82,762727;there was a significant main effect of stress exposure;significant effect;115;153;0,978364307;0,900916283;0,731108452;45,28424825;50,69769231;0,243563085;13,7;20,37;9,63;5,56;;;;;1;27,8;0,904688469;0,539231136;0,679522322;0,064215087;0,141701906;0,289261208
244;Wildtype;Heterozygous;PTEN KO;11,98;10,19;3,5;3,24;11;10;11,60818677;10,24577962;FALSCH;NS;10,98392126;-0,16296548;-14,94156928;essa comparação não é mencionada no texto;-;116;154;0,20695446;0,153291274;0,114239771;14,94156928;11,12761905;0,987086385;;;;;;;;;;-1,79;0,99770559;0,855263324;0,94508385;0,074328778;0,208312458;0,448748668
245;Wildtype;Knockout;PTEN KO;11,98;1,78;3,5;0,39;10;10;11,06797181;1,233288287;WAHR;p<0.05;7,874674596;-1,295291618;-85,14190317;KO mice had impaired memory compared to the WT mice;impaired;116;154;0,342210659;0,244633177;0,171284946;85,14190317;6,88;1,144574796;;;;;;;;;0,93;-10,2;0,999997606;0,984402295;0,99807391;0,073209713;0,200955551;0,432157628
246;Wildtype;Heterozygous;PTEN KO;62,22;61,17;5,75;4,7;11;10;19,07059254;14,862705;FALSCH;p=0.46;17,2061418;-0,061024721;-1,68756027;There was no difference in percent time freezing;no difference;117;155;0,965478689;0,868916112;0,686109674;1,68756027;61,72;0,278777411;;;;;;;;;0,14;-1,05;0,864493021;0,487061334;0,622470694;0,074328778;0,208312458;0,448748668
247;Wildtype;Knockout;PTEN KO;62,22;54,9;5,75;5,75;10;10;18,18309655;18,18309655;FALSCH;p=0.46;18,18309655;-0,402571695;-11,76470588;There was no difference in percent time freezing;no difference;117;155;0,937355992;0,812916788;0,61803504;11,76470588;58,56;0,310503698;;;;;;;;;0,14;-7,32;0,807766706;0,429431259;0,555872503;0,073209713;0,200955551;0,432157628
248;Wildtype;Heterozygous;PTEN KO;63,25;55,75;5,5;5;31;20;30,622704;22,36067977;FALSCH;NS;27,71299702;-0,270631141;-11,85770751;essa comparação não é mencionada no texto;-;118;156;0,952809582;0,841995027;0,652014102;11,85770751;60,30882353;0,459518117;;;;;;;;;;-7,5;0,825107681;0,445622001;0,574946308;0,107299559;0,414355017;0,796553894
249;Wildtype;Knockout;PTEN KO;63,25;37,75;5,5;7,5;31;12;30,622704;25,98076211;WAHR;p<0,01;29,44921217;-0,865897527;-40,31620553;KO mice froze less than the WT mice;less;118;156;0,822214329;0,652451898;0,462673142;40,31620553;56,13372093;0,524626048;;;;;;;;;0,43;-25,5;0,632402406;0,304390362;0,39984307;0,090491055;0,312608333;0,652872221
250;WT;mCREB;mCREB k.o.;62,87;45,13;6,84;3,42;9;6;20,52;8,37725492;WAHR;p<0.05;16,91484373;-1,048782967;-28,21695562;freezing was signiﬁcantly reduced in mCREB mice compared to WTmice;significantly reduced;119;157;0,896053716;0,747163354;0,549078121;28,21695562;55,774;0,303274711;;;;;;;;;1,07;-17,74;0,732738051;0,369133179;0,482476818;0,066653678;0,157756034;0,32947174
251;control;cryo 6-min;pup cryoanesthesia for 6 min;16,25;13,91;3,3;2,83;33;35;18,95705673;16,74250579;FALSCH;NS;17,85057125;-0,131088242;-14,4;There were no differences between the groups;no difference;120;158;0,402467816;0,287052199;0,198270505;14,4;15,04558824;1,18643226;;;;;;;;;0,14;-2,34;0,999599663;0,917046054;0,976341363;0,130723915;0,54013351;0,909404018
252;control;cryo 12-min;pup cryoanesthesia for 12 min;16,25;16,05;3,3;2,81;33;36;18,95705673;16,86;FALSCH;NS;17,89226715;-0,011178013;-1,230769231;There were no differences between the groups;no difference;120;158;0,405424542;0,289169299;0,199628674;1,230769231;16,14565217;1,108178658;;;;;;;;;0,14;-0,2;0,999632622;0,919303689;0,977306398;0,131856461;0,545697076;0,913012863
253;control;cryo 6-min;pup cryoanesthesia for 6 min;64,6;64,97;4,13;3,75;33;35;23,72504373;22,18529919;FALSCH;NS;22,94474965;0,016125693;0,572755418;None of the experimen-tal factors differentiated the freezing of mice;no difference;121;159;0,999620504;0,991454152;0,93153436;0,569493612;64,79044118;0,354137883;;;;;;;;;0,14;0,37;0,985112782;0,739799933;0,866055339;0,130723915;0,54013351;0,909404018
254;control;cryo 12-min;pup cryoanesthesia for 12 min;64,6;69,1;4,13;3,38;33;36;23,72504373;20,28;FALSCH;NS;21,99281782;0,204612253;6,965944272;None of the experimen-tal factors differentiated the freezing of mice;no difference;121;159;0,999967168;0,998096624;0,970700778;6,512301013;66,94782609;0,328506826;;;;;;;;;0,14;4,5;0,991374926;0,780495729;0,896619105;0,131856461;0,545697076;0,913012863
255;CTR;DER;denial expected reward;34,97;32,35;3,5;6,55;;;;;FALSCH;NS;;;-7,492136117;essa comparação não é mencionada no texto;-;122;160;;;;7,492136117;;;;;;;;;;;;-2,62;;;;;;
256;CTR;RER;receive expected reward;34,97;66,01;3,5;3,93;;;;;WAHR;p=0.001;;;88,76179582;showed that contextual memory performance was enhanced in the RER males when compared to (...) CTR.;enhanced;122;160;;;;47,02317831;;;;;;;;;;;1,14;31,04;;;;;;
257;CTRL;DER;denial expected reward;34,09;43,72;7,87;5,68;;;;;FALSCH;NS;;;28,2487533;essa comparação não é mencionada no texto;-;122;161;;;;22,02653248;;;;;;;;;;;;9,63;;;;;;
258;CTRL;RER;receive expected reward;34,09;48,96;7,87;7,43;;;;;WAHR;p=0.019;;;43,61982986;contextual fear memory was lower in the CTRL compared to the RER;lower;122;161;;;;30,37173203;;;;;;;;;;;0,5;14,87;;;;;;
259;untreated;VPA-treated;cronic treatment with acid valproic;69,05;47,55;4,53;6,41;16;12;18,12;22,20489135;WAHR;p<0,05;19,95055927;-1,077664025;-31,13685735;resulted in a significant contextual fear memory impairment;impairment;123;162;0,985273659;0,921356501;0,763406315;31,13685735;59,83571429;0,333422263;;;;;;;;;0,93;-21,5;0,855477648;0,476900267;0,610993507;0,081968385;0,258173203;0,553690588
260;eNpHR3.0;POMC-eNpHR3.0;supression of actionpotential generation;47,87;18,12;9,09;3,27;;;;;WAHR;p=0.006;;;-62,14748277;mice exhibited a robust impairment in freezing to the context;impairment;124;163;;;;62,14748277;;;;;;;;;;;0,93;-29,75;;;;;;
261;ChR2 het;POMC-ChR2;increased activity of DG;50,29;13,45;7,6;7,89;;;;;WAHR;p=0,004;;;-73,2551203;mice showed a marked decrease in freezing;marked decrease;124;163;;;;73,2551203;;;;;;;;;;;1,79;-36,84;;;;;;
262;eNpHR3.0;POMC-eNpHR3.0;supression of actionpotential generation;40,17;37,11;12,22;12,22;6;6;29,93276466;29,93276466;FALSCH;NS;29,93276466;-0,102229114;-7,617625093;froze similarly to the training context;similarly;125;163;0,185622059;0,139211726;0,105515996;7,617625093;38,64;0,77465747;;;;;;;;;0;-3,06;0,265337614;0,133604265;0,167213825;0,063856988;0,1393477;0,283285026
263;ChR2 het;POMC-ChR2;increased activity of DG;42,2;43,95;7,56;8,12;9;9;22,68;24,36;FALSCH;NS;23,53499522;0,074357355;4,146919431;in the ventral DG had no effect;no effect;125;163;0,43984316;0,314089671;0,215707457;3,981797497;43,075;0,546372495;;;;;;;;;0,21;1,75;0,545422817;0,257129674;0,337306772;0,070863494;0,1855067;0,396438439
266;Control (DMSO);H89 5uM;PKA II inhibitor;58,71;56,14;3,3;4,77;8;8;9,333809512;13,49159739;FALSCH;NS;11,60049999;-0,221542175;-4,377448476;5 μM did not show any significant alteration;no significant alteration;127;166;0,996101297;0,964731622;0,848511369;4,377448476;57,425;0,202011319;;;;;;;;;0,64;-2,57;0,977630834;0,704786094;0,837623752;0,068522551;0,170075046;0,359622486
267;Control (DMSO);H89 10uM;PKA II inhibitor;58,71;34,12;3,3;5,5;8;8;9,333809512;15,55634919;WAHR;p<0,01;12,82809417;-1,916886458;-41,8838358;10 μM concentration decreased the freezing time significantly;significant decrease;127;166;0,986740949;0,926167346;0,771543586;41,8838358;46,415;0,2763782;;;;;;;;;1,14;-24,59;0,948181845;0,617595692;0,758955732;0,068522551;0,170075046;0,359622486
268;Control (DMSO);H89 5uM;PKA II inhibitor;52,23;48,21;8,4;4,38;8;8;23,75878785;12,38851081;FALSCH;NS;18,9467042;-0,212174105;-7,69672602;essa comparação não é mencionada no texto;-;127;167;0,711200728;0,53694316;0,370368576;7,69672602;50,22;0,377274078;;;;;;;;;;-4,02;0,680454616;0,333690525;0,43770171;0,068522551;0,170075046;0,359622486
269;Control (DMSO);H89 10uM;PKA II inhibitor;52,23;23,74;8,4;4,74;8;8;23,75878785;13,40674457;WAHR;p<0,01;19,2901633;-1,47691855;-54,5471951;freezing decreased significantly for the 10 μM dose;significant decrease;127;167;0,695704579;0,52240922;0,359491374;54,5471951;37,985;0,507836338;;;;;;;;;1,14;-28,49;0,664846587;0,32387196;0,425097462;0,068522551;0,170075046;0,359622486
270;Control (DMSO);Bucladesine 50uM;cAMP analog;58,73;67,88;3,7;3,69;8;8;10,46518036;10,43689609;FALSCH;NS;10,45104779;0,875510301;15,57977184;Animals which received 50 μM bucladesine did not differ from the control group.;did not differ;127;166;0,999964065;0,997987812;0,969761999;13,47967001;63,305;0,1650904;;;;;;;;;0,14;9,15;0,992725648;0,791881678;0,904666468;0,068522551;0,170075046;0,359622486
271;Control (DMSO);Bucladesine 100uM;cAMP analog;58,73;76,09;3,7;4,17;8;8;10,46518036;11,79454111;WAHR;p<0,01;11,14969058;1,55699388;29,55899881;administration of 100 and 300 bucladesine increased post-shock freezing significantly;significantly increased;127;166;0,999990258;0,999100301;0,98086235;22,8150874;67,41;0,165401136;;;;;;;;;1,07;17,36;0,984901809;0,738659822;0,865159903;0,068522551;0,170075046;0,359622486
272;Control (DMSO);Bucladesine 300uM;cAMP analog;58,73;79,22;3,7;3,69;8;8;10,46518036;10,43689609;WAHR;p<0,001;10,45104779;1,960568969;34,88847267;administration of 100 and 300 bucladesine increased post-shock freezing significantly;significantly increased;127;166;0,999999649;0,99988528;0,99410486;25,86468064;68,975;0,151519359;;;;;;;;;1,07;20,49;0,992725648;0,791881678;0,904666468;0,068522551;0,170075046;0,359622486
273;Control (DMSO);Bucladesine 50uM;cAMP analog;52,09;54,88;8,83;7,44;8;8;24,97501151;21,04349781;FALSCH;NS;23,09307255;0,120815452;5,356114417;50 μM bucladesine did not differ from DMSO control;did not differ;127;167;0,583088074;0,424576456;0,289508237;5,083819242;53,485;0,431767272;;;;;;;;;0,14;2,79;0,513138106;0,241044472;0,315645038;0,068522551;0,170075046;0,359622486
274;Control (DMSO);Bucladesine 100uM;cAMP analog;52,09;75,34;8,83;3,72;8;8;24,97501151;10,5217489;WAHR;p<0,05;19,1632252;1,213261325;44,63428681;100 and 300 μM of post-training bucladesine improved tone conditioning;improved;127;167;0,948394825;0,833334046;0,641616935;30,86010088;63,715;0,300764737;;;;;;;;;0,79;23,25;0,670584798;0,327445658;0,429694846;0,068522551;0,170075046;0,359622486
275;Control (DMSO);Bucladesine 300uM;cAMP analog;52,09;84,18;8,83;3,72;8;8;24,97501151;10,5217489;WAHR;p<0,01;19,1632252;1,674561545;61,60491457;100 and 300 μM of post-training bucladesine improved tone conditioning;improved;127;167;0,979849584;0,90505541;0,737384797;38,12069375;68,135;0,281253764;;;;;;;;;0,79;32,09;0,670584798;0,327445658;0,429694846;0,068522551;0,170075046;0,359622486
276;SAL;AP5;NMDA receptor antagonist;40,26;11,07;16,77;7,71;10;9;53,03139636;23,13;WAHR;p=0,007;41,72101756;-0,699647365;-72,50372578;conditioned-saline (n 5 10) freezing time was significantlyhigher than that of all other groups;significantly higher;128;168;0,160118418;0,122441895;0,095128812;72,50372578;26,43315789;1,578359185;;;;;;;;;0,79;-29,19;0,22452927;0,117585537;0,144722171;0,071974211;0,192823661;0,41350208
277;WT;ITSN1 gt/gt;loss of function intersectin1;41,73;17,26;5,36;4,02;14;11;20,05528359;13,33283166;WAHR;p=0,005;17,45357968;-1,402004658;-58,63886892;Itsn1Gt/Gt and Itsn1Gt/GtItsn2-/-mice froze significantly less than Itsn2-/- and WT mice;significantly less;130;169;0,773057457;0,59845023;0,418094339;58,63886892;30,9632;0,563687851;;;;;;;;;0,79;-24,47;0,905257743;0,540072677;0,680416181;0,078672576;0,236756422;0,510245161
278;WT;ITSN2 -/-;loss of function intersectin2;41,73;29,33;5,36;7,03;14;15;20,05528359;27,22707292;FALSCH;NS;24,04253653;-0,51575257;-29,71483345;Itsn2-/- and WT micewhich did not differ;did not differ;130;169;0,568379153;0,412625194;0,281292583;29,71483345;35,3162069;0,680779128;;;;;;;;;0,14;-12,4;0,730873954;0,36779249;0,480804329;0,083788828;0,269925375;0,576469931
279;WT;ITSN1gt/gt ITSN2 -/-;loss of function intersectin1 e intersectin2;41,73;12,57;5,36;5,36;14;9;20,05528359;16,08;WAHR;p=0,002;18,64111993;-1,564283697;-69,87778577;Itsn1Gt/Gt and Itsn1Gt/GtItsn2-/-mice froze significantly less than Itsn2-/- and WT mice;significantly less;130;169;0,667103788;0,4963508;0,340326945;69,87778577;30,31956522;0,614821479;;;;;;;;;0,79;-29,16;0,823597176;0,444168535;0,573245402;0,075458745;0,215730707;0,465196835
280;WT;ITSN1 +/gt;knock out parcial sem perda de função;35,51;33,74;8,42;3,03;6;6;20,62470363;7,421953921;FALSCH;NS;15,49941612;-0,11419785;-4,984511405;Itsn1+/Gt mice froze to a similar degree as WT mice;similar;130;169;0,441066827;0,314985426;0,216288701;4,984511405;34,625;0,447636567;;;;;;;;;0;-1,77;0,729532299;0,366831446;0,479604394;0,063856988;0,1393477;0,283285026
283;ACSF/vHp;R165/vHp;anti-nectin-1;88,36;73,28;3,43;5,29;7;7;9,074926997;13,99602444;WAHR;p=0,04;11,79497774;-1,278510255;-17,06654595;R165 again showed impaired contextual fear memory;impaired;133;171;0,999995457;0,999438631;0,985373577;17,06654595;80,82;0,145941323;;;;;;;;;0,93;-15,08;0,954457838;0,632452447;0,773113384;0,066187007;0,154681378;0,321847795
284;ACSF/vHp;R165/vHp;anti-nectin-1;98;97,6;1,3;2;;;;;FALSCH;p=0.86;;;-0,408163265;no effect of the treatment was observed;no effect;134;172;;;;0,408163265;;;;;;;;;;;0,21;-0,4;;;;;;
286;Control;Arsenic;exposure to arsenic in drinking water;64,84;44,57;5,89;6,26;14;15;22,03836201;24,24487575;WAHR;p<0,05;23,20868149;-0,873380076;-31,26156693;arsenic exposed mice displayed significantly shorter freezing periods in the contextual stage;significanly shorter;136;173;0,929490926;0,799264351;0,602913378;31,26156693;54,35551724;0,426979314;;;;;;;;;0,71;-20,27;0,760523183;0,389917484;0,508184046;0,083788828;0,269925375;0,576469931
287;Control;Arsenic;exposure to arsenic in drinking water;47,65;36,45;3,12;3,38;14;15;11,67397105;13,09068371;WAHR;p<0,05;12,42873731;-0,901137398;-23,50472193;arsenic exposed mice displayed significantly shorter freezing periods (...)as well as in the cued phase of the test;significanly shorter;136;174;0,997017251;0,97001365;0,861620923;23,50472193;41,85689655;0,296934038;;;;;;;;;0,71;-11,2;0,998744432;0,880463664;0,958901223;0,083788828;0,269925375;0,576469931
288;WT;MCAT;overexpression of mithochondrial catalase;4,61;10,24;1,44;1,68;;;;;WAHR;p=0,022;;;122,1258134;with MCAT mice exhibiting significantly greater freezing than WT mice;significantly greater;137;175;;;;54,98046875;;;;;;;;;;;1,14;5,63;;;;;;
289;Dorsal Sham 1h;Dorsal lesion 1h;lesão do hipocampo dorsal;24,09;12,74;3,59;2,78;8;9;10,15405338;8,34;WAHR;p<0,005;9,231028834;-1,229548754;-47,11498547;Lesions of the DH disrupt the long-term freezing response;disrupt;129;176;0,688556003;0,515806237;0,354595292;47,11498547;18,08117647;0,510532534;;;;;;;;;1,5;-11,35;0,999237619;0,898040408;0,967690406;0,069623506;0,177333566;0,377076217
290;Ventral Sham 1h;Ventral lesion 1h;lesão do hipocampo ventral;22,93;12,16;2,54;3,93;9;9;7,62;11,79;WAHR;p=0,004;9,926441961;-1,084980907;-46,9690362;Lesions of the ventral hippocampus  also disrupt the conditioned freezing response;disrupt;138;176;0,609120497;0,446142912;0,304501028;46,9690362;17,545;0,565770417;;;;;;;;;1,5;-10,77;0,998448597;0,872148899;0,954495628;0,070863494;0,1855067;0,396438439
292;WT 4 month;TG 4 month;carrying mutant human HTT gene;77,06;31,98;4,9;6,53;13;13;17,66720125;23,54424983;WAHR;p<0,0001;20,81419828;-2,165829277;-58,49987023;TG rats expressed a significant lower freezing behaviour when re-exposed to the conditioning context;significant lower;140;177;0,99058652;0,939928777;0,796255436;58,49987023;54,52;0,381771795;0,41;0,24;0,16;0,16;;;;;0,78;-45,08;0,804694674;0,426669702;0,552591634;0,080278796;0,247214802;0,531771458
293;WT 6 month;TG 6 month;carrying mutant human HTT gene;48,84;6,67;7,51;4,9;7;9;19,86959235;14,7;WAHR;p<0,0001;17,10790168;-2,464942854;-86,34316134;TG rats expressed a significant lower freezing behaviour when re-exposed to the conditioning context;significant lower;140;177;0,734359915;0,559271825;0,387362853;86,34316134;25,119375;0,681063987;0,08;0,16;0,16;0,08;;;;;0,78;-42,17;0,760815656;0,390144817;0,508462901;0,06823031;0,168148321;0,35494991
294;WT 12 month;TG 12 month;carrying mutant human HTT gene;49,04;8,51;5,23;2,28;16;6;20,92;5,584836614;WAHR;p<0,0001;18,33118654;-2,210986174;-82,64681892;TG rats expressed a significant lower freezing behaviour when re-exposed to the conditioning context;significant lower;140;177;0,722783582;0,548015373;0,378751319;82,64681892;37,98636364;0,482572818;0,9;0,41;0,24;0,16;;;;;0,78;-40,53;0,746062339;0,378906419;0,49461695;0,070224527;0,181295508;0,386501245
295;WT young;TNFR1−/− young;TNFR1 k.o.;50;43,8;3,4;5,9;10;10;10,75174404;18,65743819;FALSCH;NS;15,22662142;-0,407181595;-12,4;essa comparação não é mencionada no texto;-;141;178;0,918030552;0,780446043;0,582812827;12,4;46,9;0,324661438;;;;;;;;;;-6,2;0,922066992;0,566702307;0,708253201;0,073209713;0,200955551;0,432157628
296;WT young;TNFR2−/− young;TNFR2 k.o.;50;25,9;3,4;3,6;10;10;10,75174404;11,38419958;WAHR;p<0.001;11,07248843;-2,176565833;-48,2;TNFR2−/−exhibited a significant reduced freezingresponse compared to the young WT;significant reduced;141;178;0,995969468;0,964014375;0,846801404;48,2;37,95;0,291765176;;;;;;;;;1,07;-24,1;0,99639366;0,833044455;0,931797092;0,073209713;0,200955551;0,432157628
297;WT aged;TNFR1−/− aged;TNFR1 k.o.;56,8;48,8;5,1;3,9;10;10;16,12761607;12,33288287;FALSCH;NS;14,35618334;-0,557251173;-14,08450704;essa comparação não é mencionada no texto;-;141;178;0,981176424;0,908859031;0,743262743;14,08450704;52,8;0,271897412;;;;;;;;;;-8;0,947811219;0,616758823;0,758149404;0,073209713;0,200955551;0,432157628
298;WT aged;TNFR2−/− aged;TNFR2 k.o.;56,8;22,2;5,1;4,7;10;10;16,12761607;14,862705;WAHR;p<0.0001;15,50806242;-2,231097546;-60,91549296;TNFR2−/−exhibited a significant reduced freezingresponse compared to the aged WT;significant reduced;141;178;0,962355629;0,861948932;0,677002637;60,91549296;39,5;0,392609175;;;;;;;;;1,07;-34,6;0,912734781;0,551470371;0,692437543;0,073209713;0,200955551;0,432157628
299;VEH:5d;MK:5d;GHSR1a agonist (MK-0677);70,81;86,6;6,69;3,82;;;;;WAHR;p<0.05;;;22,2991103;significantly enhance long-term fear memory;significantly enhance;142;179;;;;18,23325635;;;1,12;1,12;0;0;8,73;9,43;2,39;2,39;1,07;15,79;;;;;;
300;VEH-Inf:5d;MK-Inf:5d;GHSR1a agonist (MK-0677);50,9;85,51;8,71;2,56;;;;;WAHR;p<0.01;;;67,99607073;long-term fear memory was significantly enhanced;significantly enhance;143;179;;;;40,47479827;;;3,39;1,82;0;0;13,83;5,05;6,31;2,1;1,07;34,61;;;;;;
301;WT (male+female);KO (male+female);PFC mGluR5 KO;66,26;66,45;3,49;3,51;17;17;14,38963863;14,47210075;FALSCH;p=0.574;14,43092859;0,013166166;0,28674917;KO mice exhibited normal fear-conditioning behavior;normal behavior;144;180;0,999984669;0,998809689;0,977558183;0,28592927;66,355;0,217480651;;;;;;;;;0,14;0,19;0,996413877;0,833339984;0,93198029;0,089770739;0,308070035;0,645217556
302;WT (male+female);KO (male+female);PFC mGluR5 KO;13,32;19,11;2,26;4,68;17;17;9,318218714;19,29613433;FALSCH;p=0.274;15,15206257;0,382126194;43,46846847;KO mice exhibited normal fear-conditioning behavior;normal behavior;144;181;0,389340798;0,277695494;0,192281693;30,29827316;16,215;0,934447275;;;;;;;;;0,14;5,79;0,993196851;0,796200194;0,907658873;0,089770739;0,308070035;0,645217556
303;Control;CREB;CREB expression;47,95;78,01;7,69;6,44;7;6;20,34582758;15,77471394;WAHR;p<0.05;18,40929656;1,632870647;62,6903024;rats infused with LV-CREB in the striatum froze significantly more than did controls;significantly more;145;182;0,935373398;0,80941191;0,614106591;38,53352134;61,82384615;0,29777016;;;;;;;;;0,71;30,06;0,612830595;0,293177613;0,385164454;0,064931687;0,146415875;0,301168853
304;WT-Cre;gria1 dHpc;dorsalHip gria1 KO;29,01;17,74;3,34;6,05;6;7;8,181295741;16,00679543;FALSCH;NS;13,04528128;-0,863913913;-38,84867287;freezing is undistinguishable from WT;undistinguishable;146;183;0,446272829;0,31880421;0,218769351;38,84867287;22,94153846;0,568631493;8;3,08;2,2;1,04;;;;;0,14;-11,27;0,886947243;0,514607974;0,652992575;0,064931687;0,146415875;0,301168853
305;WT-Cre;gria1 vHpc;ventralHip gria1 KO;29,01;31,94;3,34;3,54;6;5;8,181295741;7,91568064;FALSCH;NS;8,064324729;0,363328623;10,09996553;freezing is undistinguishable from WT;undistinguishable;146;183;0,847534179;0,682675357;0,488956435;9,173450219;30,34181818;0,265782514;8;8,65;2,2;1,56;;;;;0,14;2,93;0,997039447;0,843119015;0,937945;0,062588441;0,131017424;0,261991073
306;Non Stress;Stress;stressed mice in adolescence;61,78;85,77;1,62;4,42;12;11;5,611844617;14,65948157;WAHR;p<0.05;10,90090603;2,200734501;38,831337;memory recall is significantly greater in stress vs non-stress animals in trace conditioned animals;significantly greater;147;185;1;0,999999788;0,999845792;27,97015273;73,25347826;0,148810764;;;;;;;;;1,14;23,99;0,999022059;0,889607928;0,963564589;0,076687438;0,22378312;0,482726232
307;Non Stress;Stress;stressed mice in adolescence;62,19;62,6;2,84;2,03;12;12;9,838048587;7,032126279;FALSCH;NS;8,550964858;0,047947806;0,659269979;CMS does not affect freezing in delay fear conditioned animals;no effect;148;186;1;0,999998799;0,9995769;0,654952077;62,395;0,137045674;;;;;;;;;0,21;0,41;0,999998184;0,98576716;0,99832004;0,077917485;0,231827529;0,499895874
308;Non Stress;Stress;stressed mice in adolescence;15,71;19,84;3,49;2,22;12;11;12,08971464;7,362907035;FALSCH;NS;10,11810541;0,408179183;26,28898791;no significant differences were observed between stress and non-stress;no significant differences;149;187;0,573185529;0,416512682;0,283957953;20,81653226;17,68521739;0,572122196;;;;;;;;;0,64;4,13;0,999756747;0,929328915;0,981421796;0,076687438;0,22378312;0,482726232
309;Non Stress;Stress;stressed mice in adolescence;36,65;35,34;1,11;3,98;12;12;3,845152793;13,78712443;FALSCH;NS;10,12101774;-0,129433624;-3,574351978;no significant differences were observed between stress and non-stress;no significant differences;150;188;0,981655489;0,910258914;0,745453971;3,574351978;35,995;0,281178434;;;;;;;;;0,64;-1,31;0,999846262;0,939057222;0,985137643;0,077917485;0,231827529;0,499895874
310;p63WT;p63 FLOX;p63 floxed trangenic;41,55;16,55;6,38;7,05;11;6;21,16006616;17,26890269;WAHR;p<0.05;19,9475295;-1,253288032;-60,16847172;had deficits in context fear memory relative to the control;deficit;151;189;0,465640247;0,333126005;0,22811259;60,16847172;32,72647059;0,609522785;;;;;;;;;0,71;-25;0,622836326;0,298862701;0,392619613;0,067972521;0,166448794;0,350814815
311;p63WT;p63 HET;p63 heterozigous trangenic;36,96;11,13;9,47;4,5;4;4;18,94;9;WAHR;p<0.05;14,82773752;-1,742005479;-69,88636364;mice showed a deficit relative to;deficit;152;189;0,363065695;0,259165676;0,180484111;69,88636364;24,045;0,616666148;;;;;;;;;0,71;-25,83;0,59277332;0,282060639;0,370511587;0,059214026;0,108954618;0,204663631
312;Veh;Mel;Melatonin injections;47,41;29,23;13,56;11,02;8;10;38,35347181;34,84829982;WAHR;p<0.01;36,4233421;-0,499130474;-38,34634043;a significantly lower freezing was observed in the melatonin group in comparison tothe vehicle group;significantly lower;153;190;0,240352196;0,175469153;0,128001958;38,34634043;37,31;0,976235382;;;;;;;;;0,79;-18,18;0,265452615;0,133649799;0,167277695;0,070603127;0,183790852;0,392399678
313;Sham 1w;MCAO 1w;middle cerebral artery occlusion;89,41;58,03;2,35;9,02;6;6;5,756300896;22,09439748;WAHR;p<0.01;16,1446183;-1,943681753;-35,09674533;observed a clear decrease in the freezing time in the contextual conditioned test at all the time points tested;clear decrease;154;191;0,992215867;0,946433903;0,808826372;35,09674533;73,72;0,218999163;;;;;;;;;1,79;-31,38;0,694498543;0,34280235;0,449322343;0,063856988;0,1393477;0,283285026
314;Sham 3w;MCAO 3w;middle cerebral artery occlusion;90,98;63,52;3,13;8,23;6;6;7,666902895;20,15930058;WAHR;p<0.05;15,25088194;-1,800551608;-30,18245768;observed a clear decrease in the freezing time in the contextual conditioned test at all the time points tested;clear decrease;154;191;0,997082296;0,970411807;0,862649638;30,18245768;77,25;0,19742242;;;;;;;;;1,79;-27,46;0,743219023;0,376792083;0,491998332;0,063856988;0,1393477;0,283285026
315;Sham 2m;MCAO 2m;middle cerebral artery occlusion;86,66;52,54;3,92;9,02;6;6;9,601999792;22,09439748;WAHR;p<0.05;17,03468227;-2,002972492;-39,3722594;observed a clear decrease in the freezing time in the contextual conditioned test at all the time points tested;clear decrease;154;191;0,980417232;0,906669839;0,739866373;39,3722594;69,6;0,244751182;;;;;;;;;1,79;-34,12;0,647903936;0,313550955;0,411758169;0,063856988;0,1393477;0,283285026
316;ACSF;APV;Arc protein inhibition;26,46;15,03;1,8;2,16;11;12;5,969924623;7,482459489;WAHR;p<0.05;6,804267568;-1,67982812;-43,19727891;subjects receiving pre-training infusions of APV froze significantly less during presentation of the CS than did subjects receiving pre-training infusions of aCSF;significantly less;155;192;0,989070523;0,934273807;0,785819502;43,19727891;20,49652174;0,331971817;;;;;;;;;0,79;-11,43;1;0,999160089;0,999974779;0,076687438;0,22378312;0,482726232
317;CON context;IRR context;gamma radiation in the head;68,59;47,41;6,79;3,19;12;9;23,52124997;9,57;WAHR;p=0.014;18,94371219;-1,118049081;-30,8791369;IRR animals spent significantly decreased percentages of time freezing compared to the COM group;significantly decreased;156;193;0,963142151;0,863680582;0,679246271;30,8791369;59,51285714;0,318312934;;;;;;;;;1,14;-21,18;0,786579758;0,410967796;0,533786839;0,073881013;0,205369894;0,44214575
318;CON cue;IRR cue;gamma radiation in the head;96,74;89,15;2,4;4;12;9;8,313843876;12;FALSCH;NS;10,03236867;-0,756551145;-7,845772173;No significant group difference was observed in freezing behavior;no difference;156;194;1;1;0,999996599;7,845772173;93,48714286;0,107312817;;;;;;;;;0,14;-7,59;0,999405232;0,90582191;0,971343677;0,073881013;0,205369894;0,44214575
319;SHAM-std;ATN-std;lesion in the ATN;54,01;50,98;4,13;6,33;;;;;FALSCH;NS;;;-5,610072209;essa comparação não é mencionada no texto;-;157;195;;;;5,610072209;;;4,49;1,15;0;0;;;;;;-3,03;;;;;;
320;Saline 3-5;Levetiracetam 3-5;anti-epileptic drug;34,27;37,15;5,23;4,97;;;;;FALSCH;NS;;;8,403851765;did not affect contextual fear conditioningin young-adult mice;did not affect;158;196;;;;7,752355316;;;;;;;;;;;0,21;2,88;;;;;;
321;Saline 17-20;Levetiracetam 17-20;anti-epileptic drug;17;33,48;2,61;4,7;;;;;WAHR;p<0,05;;;96,94117647;which showed significantly higher levels of freezing than did aged saline control mice;significantly higher;158;196;;;;49,22341697;;;;;;;;;;;0,79;16,48;;;;;;
322;Saline 17-20;Levetiracetam 17-20;anti-epileptic drug;16,94;32,82;1,85;4,5;;;;;WAHR;p<0,05;;;93,74262102;Levels of contextual freezing were significantly increased in aged mice that received an i.p. injection of 10 mg/kg levetiracetam immediately after training;significantly increased;158;197;;;;48,38513102;;;;;;;;;;;1,07;15,88;;;;;;
323;Saline 17-20;Levetiracetam 17-20;anti-epileptic drug;14,11;21,56;5,32;5,05;;;;;FALSCH;NS;;;52,79943303;levetiracetam had no significant effect when administered at a later posttraining interval;no significant effect;158;198;;;;34,55473098;;;;;;;;;;;0,21;7,45;;;;;;
324;WT sal 12-15;5XFAD sal 12-15;AD mouse model;32,75;12,62;5,13;4,05;;;;;WAHR;p<0,05;;;-61,46564885;freezing levels were significantly reduced in 5XFAD mice treated with (...) saline;significantly reduced;159;199;;;;61,46564885;;;;;;;;;;;1,07;-20,13;;;;;;
325;WT sal 6-8;5XFAD sal 6-8;AD mouse model;43,88;17,61;5,07;5,37;;;;;WAHR;p<0,05;;;-59,86782133;Similarly, (...) neither (...) affected reduced levels of freezing in 5XFAD mice;reduced;159;199;;;;59,86782133;;;;;;;;;;;0,57;-26,27;;;;;;
326;IC (impoverished condition);IE (enriched condition);mice exposed to enriched cage conditions;34,15;61,14;4,69;5,16;8;8;13,26532322;14,59468396;WAHR;p<0.01;13,94585243;1,935342435;79,03367496;mice that were housed in ICs showed a significant reduction;significant reduction;160;200;0,979459848;0,903957647;0,735708317;44,1445862;47,645;0,292703378;;;;;;;;;1,21;26,99;0,909867949;0,547022127;0,687764775;0,068522551;0,170075046;0,359622486
327;CTL;SR (sleep restriction);sleep restriction;49,68;23,93;7,61;9,79;9;10;22,83;30,95869829;WAHR;p=0.03;27,4351001;-0,938578679;-51,83172303;sleep restriction displayed a significantly  lower percentage of time freezing compared to CTL;significantly  lower;161;201;0,436193642;0,31142226;0,213978011;51,83172303;36,12736842;0,75939935;4,24;5,75;1,27;1,86;1,9;14;1,28;5,69;0,79;-25,75;0,446549203;0,209771895;0,27304579;0,071974211;0,192823661;0,41350208
328;WT;Paip2a-/-;Paip2a k.o.;33,36;47,32;3,1;4,13;10;10;9,803060747;13,06020674;WAHR;p<0.05;11,5470559;1,208966174;41,84652278;Paip2a-/- mice froze more 24 hr after weak training;more;162;202;0,986897012;0,926691408;0,77244432;29,50126796;40,34;0,286243329;1,25;1,25;0,83;0,83;;;;;0,61;13,96;0,993717814;0,801224616;0,911098379;0,073209713;0,200955551;0,432157628
329;WT;Paip2a-/-;Paip2a k.o.;47,34;32,91;4,81;4,3;10;10;15,21055555;13,59779394;WAHR;p<0.05;14,42672867;-1,000226755;-30,48162231;and froze less after strong training;less;163;203;0,917672401;0,779876065;0,582216425;30,48162231;40,125;0,35954464;0,62;0,57;0,4;0,5;;;;;0,43;-14,43;0,945914286;0,612539755;0,754070079;0,073209713;0,200955551;0,432157628
330;WT;Paip2a+/-;Paip2a k.o.;51,12;53,93;2,99;3,36;8;8;8,456997103;9,503515139;FALSCH;NS;8,995487758;0,312378837;5,49687011;similar freezing was observed 1 hr after strong contextual training;similar;164;204;0,999779027;0,993861535;0,943177141;5,210458001;52,525;0,171261071;;;;;;;;;0;2,81;0,999200075;0,896462949;0,966931612;0,068522551;0,170075046;0,359622486
331;WT;Paip2a+/-;Paip2a k.o.;47,32;64,08;4,18;3,35;8;8;11,82282538;9,475230868;WAHR;p<0.05;10,71352416;1,56437786;35,41842773;it was enhanced 24 hr after training in Paip2a+- relative to WT mice;enhanced;165;203;0,99976815;0,993678254;0,942226677;26,15480649;55,7;0,192343342;;;;;;;;;1,14;16,76;0,990242421;0,771874232;0,890375965;0,068522551;0,170075046;0,359622486
332;PBS-PBS;PBS-NPY 3pmol;Neuropeptide Y i.c.v;46,62;22,62;8,82;3,31;;;;;WAHR;p=0.04;;;-51,48005148;Post-hoc test showed less freezing behavior in PBS/NPY and PBS/LP-NPY treated rats compared to the control;less;166;205;;;;51,48005148;;;;;;;;;;;0,43;-24;;;;;;
333;PBS-PBS;PBS-LP-NPY 1pmol;Y1-agonist LP-NPY i.c.v.;46,62;16;8,82;4,96;;;;;WAHR;p=0.0083;;;-65,67996568;Post-hoc test showed less freezing behavior in PBS/NPY and PBS/LP-NPY treated rats compared to the control;less;166;205;;;;65,67996568;;;;;;;;;;;0,43;-30,62;;;;;;
334;PBS-PBS;PBS-NPY 3pmol;Neuropeptide Y i.c.v;44,23;19,31;6,65;4,45;;;;;WAHR;p=0.02;;;-56,34184942;"Post-hoc test showed less freezing behavior in PBS/NPY and PBS/LP-NPY treated rats compared
to the control PBS/PBS group";less;167;206;;;;56,34184942;;;;;;;;;;;0,43;-24,92;;;;;;
335;PBS-PBS;PBS-LP-NPY 1pmol;Y1-agonist LP-NPY i.c.v.;44,23;18,29;6,65;5,27;;;;;WAHR;p=0.03;;;-58,64797649;"Post-hoc test showed less freezing behavior in PBS/NPY and PBS/LP-NPY treated rats compared
to the control PBS/PBS group";less;167;206;;;;58,64797649;;;;;;;;;;;0,43;-25,94;;;;;;
336;Veh Context;Chon+Hyal Context;PNN blocking hipp;62;16,33;6,39;5,21;8;6;18,07364933;12,76184156;WAHR;p=0.001;16,07513764;-2,841033218;-73,66129032;When tested 48 h later, contextual, but not cue-elicited fear memory was impaired.;impaired;168;207;0,903227349;0,757676501;0,55950525;73,66129032;42,42714286;0,378888055;;;;;;;;;0,93;-45,67;0,755055606;0,385702184;0,503004216;0,065853806;0,152486651;0,31638266
337;Veh Cue;Chon+Hyal Cue;PNN blocking hipp;82,63;63,33;8,43;17,25;8;6;23,84364066;42,25369806;FALSCH;p=0.66;32,79546386;-0,588496021;-23,35713421;When tested 48 h later, contextual, but not cue-elicited fear memory was impaired.;not impaired;168;208;0,567418368;0,411850123;0,280761967;23,35713421;74,35857143;0,441044835;;;;;;;;;0,29;-19,3;0,254924748;0,129491282;0,161442843;0,065853806;0,152486651;0,31638266
338;Veh Context;Chon+Hyal Context;PNN blocking hipp;29,44;7,67;3,47;2,43;9;10;10,41;7,684334714;WAHR;p<0.001;9,069618969;-2,400321345;-73,94701087;long-term contextual memory was significantly impaired;impaired;169;209;0,897076597;0,748643678;0,550534369;73,94701087;17,98210526;0,50436914;;;;;1,79;5,39;0;0;0,93;-21,77;0,999815788;0,93539054;0,983770383;0,071974211;0,192823661;0,41350208
339;Veh Cue;Chon+Hyal Cue;PNN blocking hipp;42,56;19,98;2,69;2,37;9;10;8,07;7,494598055;WAHR;p<0.001;7,77068473;-2,905792833;-53,05451128;demonstrated significantly less freezing during both the presentation of the CS;significantly less;170;210;0,999750831;0,993393195;0,940772277;53,05451128;30,67578947;0,253316536;;;;;1,79;5,39;0;0;0,79;-22,58;0,99999635;0,982066142;0,997627369;0,071974211;0,192823661;0,41350208
340;Veh Trace;Chon+Hyal Trace;PNN blocking hipp;38,06;13,75;1,99;3,08;9;10;5,97;9,739815193;WAHR;p<0.001;8,185004941;-2,970065403;-63,87283237;demonstrated significantly less freezing during both the trace period;significantly less;170;210;0,996092534;0,964683645;0,848396503;63,87283237;25,26526316;0,323962782;;;;;1,79;5,39;0;0;0,79;-24,31;0,999983983;0,970820446;0,995084008;0,071974211;0,192823661;0,41350208
341;Veh Context;Chon+Hyal Context;PNN blocking mPFC;29,5;22,33;4,67;6,02;12;12;16,17735454;20,85389172;FALSCH;p=0.357;18,66268469;-0,384189098;-24,30508475;removal of thePNNin the mPFChad no effect on long-term contextual fear memory;no effect;171;209;0,42379387;0,302404626;0,208146584;24,30508475;25,915;0,720149901;;;;;0,46;1,83;0;0;0,21;-7,17;0,855453897;0,47687409;0,61096379;0,077917485;0,231827529;0,499895874
342;Veh Cue;Chon+Hyal Cue;PNN blocking mPFC;26,4;13,96;4,37;2,26;12;12;15,13812406;7,82886965;WAHR;p=0.019;12,05101655;-1,032278061;-47,12121212;froze significantly less during the tone presentations than did vehicle-treated controls;significantly less;172;210;0,687812385;0,515122924;0,354090203;47,12121212;20,18;0,597176242;;;;;0,46;1,83;0;0;0,79;-12,44;0,996706656;0,837755608;0,93469709;0,077917485;0,231827529;0,499895874
343;Veh Trace;Chon+Hyal Trace;PNN blocking mPFC;39,79;19,46;6,69;4,64;12;12;23,17483981;16,07343149;WAHR;p=0.021;19,94277313;-1,019416902;-51,09323951;Freezing during the trace period was also significantly reduced following mPFC PNN removal;significantly reduced;172;210;0,606842547;0,444233542;0,303164632;51,09323951;29,625;0,673173776;;;;;0,46;1,83;0;0;1,07;-20,33;0,806827261;0,428583538;0,554866215;0,077917485;0,231827529;0,499895874
344;ACSF 0h;ANI 0h;protein synthesis inhibition;41,23;17,97;6,34;6,34;8;7;17,93222797;16,77406331;WAHR;p<0.01;17,40726815;-1,336223455;-56,41523163;essa comparação não é mencionada no texto;-;173;211;0,551424771;0,399044729;0,272032843;56,41523163;30,37533333;0,573072498;0,12;0,76;0;0;;;;;;-23,26;0,723785698;0,362751276;0,474500286;0,067276248;0,161858992;0,339585243
345;ACSF 0h;ANI 1h;protein synthesis inhibition;41,23;22,73;6,34;5,81;8;9;17,93222797;17,43;WAHR;p<0.05;17,66614993;-1,047200441;-44,87024012;Anisomycin infusion 1 h after conditioning produced a decrease in freezing in response;decrease;173;212;0,591983791;0,431884689;0,29456417;44,87024012;31,43588235;0,561974044;;;;;;;;;0,57;-18,5;0,764405518;0,39295078;0,511900596;0,069623506;0,177333566;0,377076217
346;ACSF 0h;ANI 3h;protein synthesis inhibition;41,23;36,47;6,34;8,98;8;6;17,93222797;21,99641789;FALSCH;NS;19,7276574;-0,241285618;-11,54499151;In contrast, infusion 3 h after conditioning had no effect;no effect;173;213;0,423429199;0,302140462;0,207976105;11,54499151;39,19;0,503384981;;;;;;;;;0,21;-4,76;0,579183759;0,274726232;0,360791589;0,065853806;0,152486651;0,31638266
347;CLT Context;HDAC1 KO Context;histone deacetylase ko;37,74;42,74;5,25;6,69;12;11;18,18653348;22,18821985;FALSCH;NS;20,19125341;0,247631977;13,24854266;The performance of HDAC1 KO mice was indistinguishable from CTLs in both the contextual and cued fear learning paradigms;indistinguishable;174;214;0,638696455;0,47134948;0,322317033;11,69864296;40,13130435;0,503129757;;;;;;;;;0,14;5;0,779387717;0,404988706;0,526559896;0,076687438;0,22378312;0,482726232
348;CLT Context;HDAC2 KO Context;histone deacetylase ko;33,27;52,71;6,55;4,58;10;13;20,71291867;16,51342484;WAHR;p=0.023;18,43074993;1,054759035;58,43101894;In contextual fear conditioning HDAC2 KOs showed enhanced long-term memory of the context-shock pairing as evidenced by increased freezing;enhanced;175;214;0,873661526;0,716131784;0,519385048;36,88104724;44,25782609;0,416440471;;;;;;;;;1,14;19,44;0,843310491;0,463865674;0,596101846;0,076277722;0,221099749;0,476922641
349;CLT Cue;HDAC1 KO Cue;histone deacetylase ko;67,04;66;10,06;3,7;9;11;30,18;12,27151172;FALSCH;NS;22,1014821;-0,047055668;-1,551312649;The performance of HDAC1 KO mice was indistinguishable from CTLs in both the contextual and cued fear learning paradigms;indistinguishable;176;215;0,868810046;0,709717588;0,513432244;1,551312649;66,468;0,332513121;;;;;;;;;0,14;-1,04;0,639221048;0,308388009;0,405051404;0,072974857;0,19941046;0,42863838
350;CLT Cue;HDAC2 KO Cue;histone deacetylase ko;49,33;58,4;6,93;4,53;9;10;20,79;14,3251178;FALSCH;NS;17,66464365;0,513455022;18,38637746;essa comparação não é mencionada no texto;-;177;215;0,90736757;0,763890589;0,565764412;15,53082192;54,10368421;0,326496133;;;;;;;;;;9,07;0,809229215;0,430756698;0,55744436;0,071974211;0,192823661;0,41350208
351;aCSF Before Cond;CoCl2 Before Cond;non-selective synapse blocker;79,07;76,15;3,76;3,34;6;6;9,210081433;8,181295741;FALSCH;NS;8,710889736;-0,3352126;-3,692930315;no effect was observed on the percentage of freezing when CoCl2 was injected into the IC before the conditioning;no effect;178;216;0,999999909;0,999950568;0,996366308;3,692930315;77,61;0,11223927;;;;;;;;;0,21;-2,92;0,995542348;0,821525072;0,924524348;0,063856988;0,1393477;0,283285026
352;aCSF After Cond;CoCl2 After Cond;non-selective synapse blocker;84,1;56,06;1,25;4,18;6;6;3,061862178;10,23886712;WAHR;p<0.05;7,556765181;-3,710582416;-33,3412604;significantly reduced the percentage of freezing when the treatment was performed after conditioning;significantly reduced;178;217;1;0,999999909;0,99990585;33,3412604;70,08;0,107830553;;;;;;;;;1,07;-28,04;0,999540226;0,913278158;0,974700377;0,063856988;0,1393477;0,283285026
353;CON 4w female;BPA 4w female;Perinatal exposure to bisphenol A;25,38;40,84;3,52;5,15;;;;;WAHR;p<0.05;;;60,91410559;BPA-exposed juvenile females showed higher freezing scores than vehicle-exposed ones;higher;179;218;;;;37,85504407;;;1,08;1,08;0;0;;;;;0,79;15,46;;;;;;
354;CON 9w female;BPA 9w female;Perinatal exposure to bisphenol A;29,3;33,91;4,06;5,15;;;;;FALSCH;NS;;;15,7337884;does not affect fear memory in juvenile male rodents or in either male or female adult rodents;no effect;180;218;;;;13,59480979;;;0,54;1,08;0;0;;;;;0,21;4,61;;;;;;
355;CON 4w male;BPA 4w male;Perinatal exposure to bisphenol A;27,93;25,22;4,88;2,16;;;;;FALSCH;NS;;;-9,7028285;does not affect fear memory in juvenile male rodents or in either male or female adult rodents;no effect;181;219;;;;9,7028285;;;1,28;1,01;0;0;;;;;0,21;-2,71;;;;;;
356;CON 9w male;BPA 9w male;Perinatal exposure to bisphenol A;27,39;24,67;5,42;3,25;;;;;FALSCH;NS;;;-9,930631617;does not affect fear memory in juvenile male rodents or in either male or female adult rodents;no effect;182;219;;;;9,930631617;;;0,53;0,53;0;0;;;;;0,21;-2,72;;;;;;
357;CB1+/+;CB1-/-;CB1 KO;51,83;73,68;6,86;4,41;8;8;19,40301008;12,47336362;WAHR;p<0.01;16,31045064;1,339631901;42,1570519;MOVE software system revealed significantly (P <0.01) higher fear responses for the CB1–/– as compared to the CB1+/+ animals;significantly higher;183;220;0,98478224;0,919789124;0,76080419;29,65526602;62,755;0,25990679;;;;;;;;;0,79;21,85;0,805530495;0,427418057;0,553481504;0,068522551;0,170075046;0,359622486
358;WT;GluD1 KO;Glutamate delta-1 KO;67,06;16,66;11,9;10,31;8;6;33,65828278;25,25423925;WAHR;p=0.0108;30,43989022;-1,655722134;-75,1565762;freezing response was significantly lower in GluD1 KO mice versus WT mice;significantly lower;184;221;0,461111582;0,329760524;0,225911229;75,1565762;45,46;0,669597233;;;;;;;;;0,79;-50,4;0,288034601;0,142641005;0,179880418;0,065853806;0,152486651;0,31638266
359;WT;GluD1 KO;Glutamate delta-1 KO;75,68;35,78;5,96;10,55;6;6;14,59895887;25,84211679;WAHR;p=0.0093;20,98743195;-1,90113779;-52,72198732;GluD1 KO mice manifest a significant deficit in the freezing versus WT mice;significant deficit;185;222;0,813591631;0,642571824;0,454301976;52,72198732;55,73;0,376591279;0;0;0;0;;;;;1,14;-39,9;0,475738665;0,223194228;0,291403884;0,063856988;0,1393477;0,283285026
360;Control;Stress at 1h;cold swim stress;40,69;59,3;4,65;6,2;;;;;WAHR;p<0.05;;;45,73605308;stress administered 1 h after fear conditioning enhanced the time spent freezing;enhanced;186;223;;;;31,38279933;;;;;;;;;;;1,14;18,61;;;;;;
361;Control;Corticosterone 1h;corticosterone;45,06;64,37;4,72;6;;;;;WAHR;p<0.05;;;42,85397248;corticosterone administered 1 h after fear conditioning enhanced the time spent freezing in the tests;enhanced;187;223;;;;29,99844648;;;;;;;;;;;1,14;19,31;;;;;;
362;Vehicle;Vortioxetine 1mg/kg;Vortioxetine antidepressant;24,52;23,09;4,52;5,23;16;8;18,08;14,79267386;FALSCH;NS;17,10270898;-0,083612485;-5,831973899;whereas 5 mg/kg produced a non-significant increase;non-significant increase;188;224;0,327152416;0,234228826;0,164725089;5,831973899;24,04333333;0,711328531;1,37;1,14;0,23;0;;;;;1,5;-1,43;0,874331356;0,498704304;0,635477854;0,074776728;0,211254607;0,455306226
363;Vehicle;Vortioxetine 5mg/kg;Vortioxetine antidepressant;24,52;39,52;4,52;13,57;16;6;18,08;33,23957581;FALSCH;NS;22,83379403;0,656921052;61,17455139;1 mg/kg did not have any effect;no effect;188;224;0,378620368;0,270104133;0,187438695;37,95546559;28,61090909;0,79807999;1,37;1,26;0,23;0,23;;;;;0,21;15;0,5577033;0,263432613;0,345745025;0,070224527;0,181295508;0,386501245
364;Vehicle;Vortioxetine 10mg/kg;Vortioxetine antidepressant;24,52;52,14;4,52;5,71;16;8;18,08;16,15031888;WAHR;p<0.01;17,48912077;1,579267498;112,6427406;Post hoc tests indicated a significant increase in freezing at 10 mg/kg compared to the vehicle control group (P<0.01);significant increase;188;224;0,881601031;0,726852629;0,529470765;52,97276563;33,72666667;0,518554678;1,37;1,49;0,23;0;;;;;1,07;27,62;0,85958545;0,481473517;0,616173485;0,074776728;0,211254607;0,455306226
365;Vehicle;Vortioxetine 5mg/kg;Vortioxetine antidepressant;25,27;45,59;3,54;5,19;19;8;15,43050226;14,67953678;WAHR;p<0.05;15,22396637;1,334737578;80,4115552;vortioxetine treatment also caused increased freezing rates during retention;increase;189;225;0,900359124;0,753435706;0,555275125;44,57117789;31,29074074;0,486532629;1,25;0,9;0,22;0,22;;;;;0,71;20,32;0,948045201;0,617286663;0,75865809;0,076171524;0,220403927;0,47541152
366;Vehicle;Vortioxetine 10mg/kg;Vortioxetine antidepressant;25,27;31,89;3,54;5,43;19;19;15,43050226;23,66882126;FALSCH;NS;19,97890763;0,331349447;26,19707163;At 10 mg/kg dose, there was a trend towards an increase that did not reach statistical significance;trend towards an increase;189;225;0,61253944;0,449016962;0,306516018;20,75885858;28,58;0,699052051;1,25;1,25;0,22;0,34;;;;;1,86;6,62;0,944066709;0,608529314;0,750170539;0,094543085;0,337890748;0,693506844
367;Control;hM4Di;DREADDs injection;52,36;23,24;8,76;6,05;9;15;26,28;23,43154924;WAHR;p<0.01;24,50568784;-1,188295558;-55,61497326;hM4Di mice showed impaired fear memory recall compared with control;impaired;190;226;0,638097003;0,470830586;0,321946923;55,61497326;34,16;0,717379621;;;;;;;;;0,93;-29,12;0,605275198;0,288947418;0,379600317;0,076149717;0,220261028;0,475100871
368;cel-miR-67OE;rno-miR-182OE;miR-182 overexpression;44,7;12;7,8;5,4;;;;;WAHR;p<0.005;;;-73,15436242;rno-miR-182OE disrupted freezing at the 24 h test;disrupted;191;227;;;;73,15436242;;;;;;;;;;;1,5;-32,7;;;;;;
369;cel-miR-67OE;rno-miR-182OE;miR-182 overexpression;39,1;30,53;13,95;6,41;;;;;FALSCH;NS;;;-21,91815857;STM was equivalent between the two groups at the 90 min post-training test;equivalent;192;228;;;;21,91815857;;;;;;;;;;;0;-8,57;;;;;;
370;Sal;Pitolisant 0.625;H3R inverse agonist;34,25;31,46;4,49;3,42;12;12;15,55381625;11,84722752;FALSCH;NS;13,82530289;-0,201803897;-8,145985401;the effect induced by the two lower doses of Pitolisant did not statistically differ;did not statistically differ;193;229;0,791082729;0,617632083;0,433610927;8,145985401;32,855;0,420797531;;;;;;;;;0,64;-2,79;0,982862393;0,72817477;0,856827985;0,077917485;0,231827529;0,499895874
371;Sal;Pitolisant 1.25;H3R inverse agonist;34,25;41,74;4,49;2,99;12;12;15,55381625;10,35766383;FALSCH;NS;13,21367473;0,566837019;21,86861314;the effect induced by the two lower doses of Pitolisant did not statistically differ;did not statistically differ;193;229;0,942052063;0,82140558;0,627690331;17,94441782;37,995;0,347774042;;;;;;;;;0,64;7,49;0,989431353;0,766120625;0,886139054;0,077917485;0,231827529;0,499895874
372;Sal;Pitolisant 2.5;H3R inverse agonist;34,25;51,37;4,49;4,28;12;12;15,55381625;14,82635491;WAHR;p=0.015;15,19443977;1,126727952;49,98540146;"The freezing values derived from the groups having received the two highest doses of this H3R
inverse agonist (2.5 or 5 mg/kg) were significantly greater than that of the saline group";significantly greater;193;229;0,965656024;0,869319292;0,686643329;33,32684446;42,81;0,354927348;;;;;;;;;1,14;17,12;0,959895032;0,646536608;0,786256824;0,077917485;0,231827529;0,499895874
373;Sal;Pitolisant 5;H3R inverse agonist;34,25;47,3;4,49;4,28;12;12;15,55381625;14,82635491;WAHR;p=0.048;15,19443977;0,858866809;38,10218978;"The freezing values derived from the groups having received the two highest doses of this H3R
inverse agonist (2.5 or 5 mg/kg) were significantly greater than that of the saline group";significantly greater;193;229;0,935863395;0,810273979;0,615069787;27,58985201;40,775;0,372641074;;;;;;;;;1,14;13,05;0,959895032;0,646536608;0,786256824;0,077917485;0,231827529;0,499895874
374;sal;flx;fluoxetine administration;53,55;74,86;8,19;6,01;13;14;29,52946495;22,48736089;WAHR;p<0.05;26,10573102;0,816295854;39,7945845;elicited significantly higher freezing in fluoxetine;significantly higher;194;230;0,924882636;0,791556271;0,594581259;28,46647075;64,59962963;0,4041158;;;;;37,76;41,98;5,75;4,98;0,79;21,31;0,628725002;0,302254448;0,397054868;0,081417438;0,254604988;0,54662515
375;sal CeA;flx CeA;fluoxetine administration;47,25;43,95;6,04;6,59;11;5;20,03241373;14,73568797;FALSCH;p=0.80;18,67300955;-0,176725663;-6,984126984;intra-CeA fluoxetine infusions before conditioning also did not affect freezing;no effect;195;230;0,572108132;0,415639783;0,283358887;6,984126984;46,21875;0,404013729;;;;;1,69;5,63;0;4,22;0,21;-3,3;0,627309503;0,301435973;0,395985443;0,06589545;0,152760923;0,317066666
376;sal BNST;6 ug flx BNST;fluoxetine administration;50,47;51,46;5,49;5,5;9;6;16,47;13,47219359;FALSCH;p=0.99;15,3862756;0,064343056;1,961561324;Although the lower dose of 6 mg per side did not affect memory recall;no effect;196;230;0,825595944;0,656380418;0,466030737;1,92382433;50,866;0,302486447;;;;;2,85;0,28;3,49;0;0,21;0,99;0,809900345;0,431367284;0,558167843;0,066653678;0,157756034;0,32947174
377;sal BNST;9 ug flx BNST;fluoxetine administration;50,47;80,47;5,49;3,28;9;8;16,47;9,277240969;WAHR;p<0.01;13,59548356;2,20661515;59,44125223;dose of 9 mg per side was sufficient to elicit a significant enhancement in fear memory during the testing session;significant enhancement;196;230;0,999841282;0,994988045;0,949319239;37,28097428;64,58764706;0,210496654;;;;;;;;;1,21;30;0,936135483;0,592300398;0,734174436;0,069623506;0,177333566;0,377076217
378;WT;KO;PKM-zeta KO;51,5;39,3;5,75;5,76;13;15;20,73191983;22,30838407;FALSCH;NS;21,59509025;-0,564943228;-23,68932039;mice exhibit similar contextual freezing behaviour;similar;197;231;0,819381308;0,649184381;0,459893201;23,68932039;44,96428571;0,480272063;2,62;2,62;0;0;7,06;4,64;0;0;0;-12,2;0,802876134;0,425049087;0,550662557;0,082475732;0,261454441;0,56012651
380;wild-type;Prkcz-/-;PKM-zeta KO;54,12;53,47;3,24;2,91;20;27;14,48972049;15,12080355;FALSCH;NS;14,85761623;-0,043748606;-1,201034738;similar levels of freezing during all three sessions;similar;198;231;0,999881716;0,995815057;0,954227085;1,201034738;53,74659574;0,276438275;;;;;14,19;17,41;2,25;2,58;0;-0,65;0,999498182;0,910810856;0,973605545;0,104084737;0,395569528;0,773889626
381;WT 1h;PML KO 1h;promyelocytic leukemia OK;65,99;23,22;5,89;5,81;8;10;16,65943576;18,37283321;WAHR;p<0.05;17,64370745;-2,424093696;-64,81285043;mice showing a significant decreased freezing behavior as compared to the control group;significant decrease;199;232;0,949445403;0,835366626;0,644034521;64,81285043;42,22888889;0,417811311;2,54;5,81;2,18;3,27;;;;;1,14;-42,77;0,785068166;0,409699752;0,53225718;0,070603127;0,183790852;0,392399678
382;WT 24h;PML KO 24h;promyelocytic leukemia KO;38,34;16,59;4,42;5,53;8;10;12,50164789;17,48739546;WAHR;p<0.05;15,5046755;-1,402802657;-56,72926448;mice showing a significant decreased freezing behavior as compared to the control group;significant decrease;199;233;0,662701483;0,492421655;0,337472957;56,72926448;26,25666667;0,590504336;2,54;5,81;2,18;3,27;;;;;1,14;-21,75;0,878743371;0,504133423;0,641489945;0,070603127;0,183790852;0,392399678
383;WT 1h;PML KO 1h;promyelocytic leukemia KO;47,33;31,92;6,23;6,23;8;10;17,62110099;19,70098982;FALSCH;NS;18,8193441;-0,818838314;-32,55863089;learning showed similar freezing levels during pre-training, training and cue testing 1 and 24 h post-training;similar;200;234;0,677393082;0,50561696;0,34709382;32,55863089;38,76888889;0,485423871;0,74;0,55;0,55;0;;;;;0;-15,41;0,73160567;0,368317998;0,481460096;0,070603127;0,183790852;0,392399678
384;WT 24h;PML KO 24h;promyelocytic leukemia KO;45,87;38,89;4,03;7,33;8;10;11,39856131;23,17949525;FALSCH;NS;18,9490953;-0,368355317;-15,21691738;learning showed similar freezing levels during pre-training, training and cue testing 1 and 24 h post-training;similar;200;235;0,644198933;0,476128728;0,325732785;15,21691738;41,99222222;0,451252501;0,74;0,55;0,55;0;;;;;0;-6,98;0,725755916;0,364143621;0,476243809;0,070603127;0,183790852;0,392399678
385;WT Context;AhR-/- Context;AhR deletion;71,77;60,18;4,11;3,73;10;10;12,99696118;11,79529567;WAHR;p<0.05;12,41068088;-0,933873017;-16,14880869;AhR-/- mice froze significantly less to the conditioned context than age-matched wild-types;significantly less;201;236;0,999959772;0,99784307;0,968547012;16,14880869;65,975;0,188111874;0;0,48;0;0;0;0;0;0;0,79;-11,59;0,985585382;0,742395547;0,868086135;0,073209713;0,200955551;0,432157628
386;WT Auditory;AhR-/- Auditory;AhR deletion;28,54;25,16;6;6,75;10;10;18,97366596;21,34537421;FALSCH;NS;20,19436803;-0,167373398;-11,84302733;freezing to the auditory stimulus did not vary by genotype;no variation;202;237;0,302788942;0,217540062;0,15424396;11,84302733;26,85;0,75211799;0;0,48;0;0;0;0;0;0;0,21;-3,38;0,721693947;0,361280385;0,47265643;0,073209713;0,200955551;0,432157628
387;Veh Context;TCDD Context;6w AhR activation;56,39;45,45;4,31;3,31;10;10;13,62941672;10,46713906;WAHR;p<0.05;12,15158426;-0,900294132;-19,40060294;TCDD exposed mice exhibited a 19% reduction in freezing to the conditioned context compared to vehicle-exposed mice;reduction;203;238;0,997256371;0,971495147;0,865480555;19,40060294;50,92;0,238640696;0;0;0;0;0;0;0;0;0,57;-10,94;0,988523324;0,760034155;0,881596399;0,073209713;0,200955551;0,432157628
388;Veh Auditory;TCDD Auditory;6w AhR activation;26,98;28,13;1,14;5,23;10;10;3,604996533;16,53871216;FALSCH;NS;11,96923139;0,096079687;4,262416605;with no differences with TCDD exposure;no difference;204;239;0,669686824;0,498665975;0,342012858;4,088162105;27,555;0,434376026;0;0;0;0;0;0;0;0;0,14;1,15;0,990324994;0,77247849;0,890817679;0,073209713;0,200955551;0,432157628
389;Veh Context;TCDD Context;4w AhR activation;56,14;50,11;4,59;3,6;10;10;14,51485446;11,38419958;FALSCH;NS;13,04379163;-0,462288894;-10,74100463;there was no difference in freezing behavior to the conditioned context between vehicle- and TCDD-exposed mice;no difference;205;240;0,992520522;0,947708973;0,811369721;10,74100463;53,125;0,245530195;0;0;0;0;0;0;0;0;0,14;-6,03;0,97640488;0,699873581;0,833483856;0,073209713;0,200955551;0,432157628
390;Veh Auditory;TCDD Auditory;4w AhR activation;26,98;27,95;1,14;5,39;10;10;3,604996533;17,04467659;FALSCH;NS;12,31902999;0,078739966;3,595255745;with no differences with TCDD exposure;no difference;206;241;0,639087801;0,471688421;0,322558867;3,470483005;27,465;0,448535591;0;0;0;0;0;0;0;0;0,14;0,97;0,986676745;0,748625576;0,872916093;0,073209713;0,200955551;0,432157628
391;Sevo - H2 - (red);Sevo + H2 - (blue);sevoflurane;55,8;41,56;3,41;2,56;18;20;14,46740474;11,44866804;WAHR;p<0.01;12,96208852;-1,098588393;-25,51971326;mice exposed to sevoflurane was significantly reduced in the contextual test compared with control;significantly reduced;207;242;0,99997831;0,998525683;0,974655966;25,51971326;48,30526316;0,268336982;;;;;;;;;1,07;-14,24;0,999770764;0,930667952;0,981949892;0,094417284;0,337112398;0,692306188
392;Sevo - H2 - (red);Sevo + H2 - (blue);sevoflurane;46,8;28,29;3,4;2,76;18;20;14,42497834;12,34309524;WAHR;p<0.001;13,36667498;-1,384787169;-39,55128205;freezing responses of mice exposed to sevoflurane and subjected to cued fear conditioning were also significantly reduced compared with controls;significantly reduced;208;243;0,998459585;0,979923216;0,889419261;39,55128205;37,05789474;0,360697095;;;;;;;;;1,07;-18,51;0,99957889;0,915688015;0,975754264;0,094417284;0,337112398;0,692306188
393;Vehicle STM;Garcinol STM;Histone Acetyltransferase Inhibitor;88,54;89,23;1,46;2,93;9;8;4,38;8,287291476;FALSCH;NS;6,502459022;0,106113702;0,779308787;vehicle and garcinol-infused rats exhibited equivalent levels freezing during the STM;equivalent;209;244;1;1;1;0,773282528;88,86470588;0,073172571;;;;;;;;;0;0,69;0,999999949;0,995680515;0,999715248;0,069623506;0,177333566;0,377076217
394;Vehicle LTM delayed;Garcinol LTM delayed;Histone Acetyltransferase Inhibitor;81,65;76,82;1,47;2,56;8;6;4,157787873;6,270693742;FALSCH;NS;5,144725454;-0,938825607;-5,915492958;when rats were given intra-LA infusion of garcinol 6 hr following training there was no effect on LTM;no effect;209;245;1;1;1;5,915492958;79,58;0,064648473;;;;;;;;;0,21;-4,83;1;0,999433313;0,999985886;0,065853806;0,152486651;0,31638266
395;Vehicle STM;Garcinol STM;Histone Acetyltransferase Inhibitor;82,59;79,7;1,55;2,32;8;7;4,384062043;6,138143042;FALSCH;NS;5,266737422;-0,548726805;-3,49921298;As in our previous experiments, we found that intra-LA infusion garcinol had no effect on STM;no effect;210;244;1;1;1;3,49921298;81,24133333;0,064828299;;;;;;;;;0,21;-2,89;1;0,999604486;0,999991692;0,067276248;0,161858992;0,339585243
396;Vehicle STM;c646 STM;Histone Acetyltransferase Inhibitor;88,66;84,59;2,03;3,19;9;7;6,09;8,439946682;FALSCH;NS;7,191766125;-0,565924966;-4,59057072;vehicle- and c646-infused rats exhibited equivalent freezing levels during the STM test;equivalent;212;244;1;1;0,99999993;4,59057072;86,879375;0,082778751;;;;;;;;;0;-4,07;0,999994302;0,979226984;0,997044318;0,06823031;0,168148321;0,35494991
397;Vehicle LTM delayed;c646 LTM delayed;Histone Acetyltransferase Inhibitor;81,1;82,26;1,83;6,39;8;6;5,176021638;15,65223946;FALSCH;NS;10,84935252;0,106918823;1,430332922;intra-LA infusion of c646 6 h following training, there was no effect on LTM;no effect;212;245;0,999995685;0,999456185;0,985636305;1,410162898;81,59714286;0,132962407;;;;;;;;;0,21;1,16;0,975414901;0,696035708;0,830224345;0,065853806;0,152486651;0,31638266
398;Vehicle STM;c646 STM;Histone Acetyltransferase Inhibitor;82,59;81,94;1,88;3,55;8;7;5,317442995;9,392417154;FALSCH;NS;7,479363404;-0,086905792;-0,78702022;As in our previous experiments, we found that intra-LA infusion of c646 had no effect on STM;no effect;213;244;1;0,999999999;0,999992962;0,78702022;82,28666667;0,090893989;;;;;;;;;0,21;-0,65;0,999966165;0,962732442;0,992904716;0,067276248;0,161858992;0,339585243
399;Vehicle;SB 334867;Orexin receptor 1 antagonist;64,3;39,1;6;4;;;;;WAHR;p=0.003;;;-39,19129082;When SB 334867 infusions were made before training, freezing was impaired during LTM;impaired;218;246;;;;39,19129082;;;;;;;;;;;0,93;-25,2;;;;;;
400;Vehicle;SB 334867;Orexin receptor 1 antagonist;66;64;6;6;;;;;FALSCH;p=0.85;;;-3,03030303;we infused SB 334867 immediately following training and found no effect on LTM freezing behavior;no effect;218;247;;;;3,03030303;;;;;;;;;;;0,21;-2;;;;;;
401;Vehicle;TCSOX2-29;Orexin receptor 2 selective antagonist;64;63;6;5;8;8;16,97056275;14,14213562;FALSCH;p=0.89;15,62049935;-0,06401844;-1,5625;with the selective OrxR2 antagonist TCSOX2-29 at an effective dose before training (30). We found no effect on learning,;no effect;218;246;0,962524295;0,862319022;0,677481071;1,5625;63,5;0,245992116;;;;;;;;;0,21;-1;0,837974296;0,458371156;0,589768408;0,068522551;0,170075046;0,359622486
402;Vehicle;SB 300ng;Orexin receptor 1 antagonist;73,1;73,2;4;4;;;;;FALSCH;NS;;;0,136798906;essa comparação não é mencionada no texto;-;219;246;;;;0,136612022;;;;;;;;;;;;0,1;;;;;;
403;Vehicle;SB 1ug;Orexin receptor 1 antagonist;73,1;47,9;4;3;;;;;WAHR;p<0.001;;;-34,47332421;pharmacological blockade of OrxR1 signaling in LC before conditioning  (...)  reduced threat memory formation;reduced;219;246;;;;34,47332421;;;;;;;;;;;0,57;-25,2;;;;;;
404;Vehicle;SB 1ug;Orexin receptor 1 antagonist;72;79;6;5;5;5;13,41640786;11,18033989;FALSCH;p=0.41;12,34908904;0,566843431;9,722222222;pharmacological blockade of OrxR1 signaling in LC before conditioning  (...)  but not immediately after conditioning  reduced threat memory formation;not reduced;220;247;0,996063801;0,964526643;0,848021102;8,860759494;75,5;0,163564093;;;;;;;;;0,29;7;0,837974296;0,458371156;0,589768408;0,061532618;0,124097265;0,244141207
405;Vehicle;SB 1ug;Orexin receptor 1 antagonist;81;61;3;3;;;;;WAHR;p<0.001;;;-24,69135802;we found that SB 334867 infusion before training reduced STM freezing;reduced;220;248;;;;24,69135802;;;;;;;;;;;0,57;-20;;;;;;
406;mCherry-Light;CHR2-light;Optical stimulation of orexin fibers in LC;51;78;3;5;;;;;WAHR;p<0.01;;;52,94117647;Optically stimulated ChR2-expressing animals froze significantly more than both the animals expressing mCherry alone and no-light controls during LTM;significantly more;221;251;;;;34,61538462;;;;;;;;;;;0,71;27;;;;;;
407;Control;Lesion;lesion in the lateral habenula;26,7;1,6;3,5;0,1;6;6;8,5732141;0,244948974;WAHR;p<0.001;6,06465168;-4,13873728;-94,00749064;the lesioned rats exhibited a reduced level of freezing;reduced;222;249;0,935877427;0,810298706;0,615097443;94,00749064;14,15;0,428597292;;;;;;;;;0,57;-25,1;0,999998002;0,985309904;0,998238835;0,063856988;0,1393477;0,283285026
408;Control;Lesion;lesion in the lateral habenula;60,41;7,3;10,57;0,91;6;6;25,89110658;2,229035666;WAHR;p<0.001;18,37549999;-2,890261491;-87,91590796;essa comparação não é mencionada no texto;-;222;250;0,738728943;0,563572091;0,390677253;87,91590796;33,855;0,542770639;;;;;;;;;;-53,11;0,582766312;0,276644969;0,363338402;0,063856988;0,1393477;0,283285026
409;ChR2-no light;ChR2-light;Optical stimulation of orexin fibers in LC;55;78;5;5;;;;;WAHR;p<0.01;;;41,81818182;Optically stimulated ChR2-expressing animals froze significantly more than both the animals expressing mCherry alone and no-light controls during LTM;significantly more;221;251;;;;29,48717949;;;;;;;;;;;0,71;23;;;;;;
410;Vehicle;Tat-GluA1d peptide;blocked low-threshold potentiation;68,81;67,48;4,88;5,77;15;13;18,90015873;20,80403086;FALSCH;p=0.84;19,80162814;-0,067166194;-1,932858596;GluA1D peptide did not affect the phosphorylation of the CaMKII substrates, which is in turn required for amygdala LTP and fear conditioning;did not affect;223;252;0,987003959;0,927051999;0,773065782;1,932858596;68,1925;0,290378387;;;;;;;;;0,21;-1,33;0,865769816;0,48853823;0,624129188;0,082475732;0,261454441;0,56012651
411;ALT-PRE;PRE;pre exposure to context;8,3;30,04;1,18;5,13;8;10;3,337544007;16,2224844;WAHR;p<0.002;12,36551505;1,758115203;261,9277108;demonstrated that PRE animals froze significantly more during retention testing;significantly more;224;253;0,647292171;0,478828416;0,327667794;72,3701731;20,37777778;0,606813716;;;;;;;;;0,71;21,74;0,9751763;0,695126982;0,829449337;0,070603127;0,183790852;0,392399678
412;Saline;VPA;Valproate induced model of autism;36,96;59,52;6,3981;9,5121;11;10;21,22009707;30,07990133;FALSCH;p=0,07;25,79894875;0,874454235;61,03896104;whereas no difference in freezing was found between groups;no difference;225;254;0,673806704;0,502373818;0,344719561;37,90322581;47,70285714;0,54082607;2,61;8,57;0;4,28;10,23;7,61;3,57;5;0,14;22,56;0,532433802;0,25057672;0,32850369;0,074328778;0,208312458;0,448748668
413;Non-transgenic;Tg2576;Transgenic alzheimer model;59,59;25,5;6,71;4,83;15;14;25,98771825;18,07220518;WAHR;p<0.001;22,52646246;-1,513331268;-57,20758517;Tg2576 (n=14) mice showed significantly less freezing than wt mice;significantly less;226;255;0,901414049;0,754989529;0,556821208;57,20758517;43,13275862;0,522258793;;;;;;;;;0,79;-34,09;0,784880908;0,409543092;0,532068086;0,083788828;0,269925375;0,576469931
414;Non-transgenic;Tg2576;Transgenic alzheimer model;26,84;12,08;6,44;4,02;15;14;24,94201275;15,04146269;WAHR;p<0.01;20,77271073;-0,710547612;-54,99254844;Tg2576 (n=14) mice showed significantly less freezing than wt mice;significantly less;226;256;0,354869127;0,253436366;0,176852103;54,99254844;19,71448276;1,053677694;;;;;;;;;0,79;-14,76;0,846336363;0,467039442;0,599745101;0,083788828;0,269925375;0,576469931
415;WT;Less-excit;k.o. of  P/Q-type Ca2-channels;19,6;18,9;4,5;4,2;10;11;14,23024947;13,92982412;FALSCH;p=0.91;14,07293034;-0,049740884;-3,571428571;no differences between genotypes were found in the contextual learning;no differences;227;257;0,307153257;0,220517071;0,15611017;3,571428571;19,23333333;0,731694818;3;5,7;1,2;1,3;;;;;0,14;-0,7;0,962638858;0,654159305;0,793255667;0,074328778;0,208312458;0,448748668
416;WT;Less-excit;k.o. of  P/Q-type Ca2-channels;33,1;33,1;4,4;5,7;10;11;13,9140217;18,90476131;FALSCH;p=0.99;16,72738064;0;0;For the cued learning, only the no-inhib mice showed a significant difference;no differences;227;258;0,54281236;0,392222441;0,267410406;0;33,1;0,505358932;;;;;;;;;0,14;0;0,882648586;0,509055512;0,646911066;0,074328778;0,208312458;0,448748668
417;WT;No-inhib;"selectively ablating the
 2 subunit of the GABAA-receptors";35;23,7;7,4;5,6;8;9;20,93036072;16,8;FALSCH;p=0.24;18,8405237;-0,599771014;-32,28571429;no differences between genotypes were found in the contextual learning;no differences;227;257;0,41510076;0,296123185;0,204098089;32,28571429;29,01764706;0,649278133;7;2,8;2,2;1,3;;;;;0,14;-11,3;0,710028985;0,353211905;0,462506195;0,069623506;0,177333566;0,377076217
418;WT;No-inhib;"selectively ablating the
 2 subunit of the GABAA-receptors";41,5;13,7;9,1;3;8;9;25,73868684;9;WAHR;p=0.02;18,77118359;-1,480993453;-66,98795181;For the cued learning, only the no-inhib mice showed a significant difference;significant difference;227;258;0,546616076;0,39522937;0,269445386;66,98795181;26,78235294;0,700878807;;;;;;;;;0,86;-27,8;0,713198616;0,355382272;0,465242479;0,069623506;0,177333566;0,377076217
419;WT;No-LTP;calcium/calmodulin-activated protein-phosphatase-2B is selectively impaired;28,6;29;14,8;16,5;8;8;41,86072145;46,66904756;FALSCH;p=0.30;44,3301252;0,009023209;1,398601399;no differences between genotypes were found in the contextual learning;no differences;227;257;0,091764725;0,077595629;0,067281159;1,379310345;28,8;1,539240458;1,3;1,4;0,5;0,7;;;;;0,14;0,4;0,179663455;0,100215199;0,120306184;0,068522551;0,170075046;0,359622486
420;WT;No-LTP;calcium/calmodulin-activated protein-phosphatase-2B is selectively impaired;35,5;49,8;8,5;7,1;8;8;24,04163056;20,08183259;FALSCH;p=0.22;22,15039503;0,645586681;40,28169014;For the cued learning, only the no-inhib mice showed a significant difference;no differences;227;258;0,536960543;0,38761517;0,264299498;28,71485944;42,65;0,519352756;;;;;;;;;0,14;14,3;0,546855038;0,257859268;0,338285005;0,068522551;0,170075046;0,359622486
421;WT;No-LTD;pseudosubstrate PKC inhibitor, PKC[19–31], is selectively expressed;34,9;28,9;8,1;5,7;10;13;25,61444905;20,55164227;FALSCH;p=0.62;22,85913384;-0,262477137;-17,19197708;no differences between genotypes were found in the contextual learning;no differences;228;257;0,381095628;0,271853029;0,188553197;17,19197708;31,50869565;0,725486516;7,6;5,5;2,3;0,81;;;;;0,14;-6;0,667556257;0,325554412;0,427263238;0,076277722;0,221099749;0,476922641
422;WT;No-LTD;pseudosubstrate PKC inhibitor, PKC[19–31], is selectively expressed;30;33,2;5,7;5,8;10;13;18,02498266;20,9121974;FALSCH;p=0.8;19,72663174;0,162217252;10,66666667;For the cued learning, only the no-inhib mice showed a significant difference;no differences;228;258;0,447012906;0,319348125;0,21912303;9,638554217;31,80869565;0,620164749;;;;;;;;;0,14;3,2;0,79194188;0,415516536;0,539260556;0,076277722;0,221099749;0,476922641
423;control;no-inhib(  2);"selectively ablating the
 2 subunit of the GABAA-receptors";28;27;8;6;9;8;24;16,97056275;FALSCH;p=0.95;21,01428086;-0,047586687;-3,571428571;no difference in the amount of freezing at the cued test;no differences;229;259;0,240073441;0,175283238;0,127886437;3,571428571;27,52941176;0,763339262;;;;;;;;;0,14;-1;0,6154292;0,294644859;0,387091032;0,069623506;0,177333566;0,377076217
424;control;no-inhib(  2);"selectively ablating the
 2 subunit of the GABAA-receptors";23;18;7;6;9;8;21;16,97056275;FALSCH;p=1.00;19,22498375;-0,260078243;-21,73913043;we confirmed the absence of phenotype effect in the contextual test;no effect;230;260;0,202593155;0,150408021;0,112452737;21,73913043;20,64705882;0,931124569;;;;;;;;;0,21;-5;0,692591236;0,341548644;0,447727863;0,069623506;0,177333566;0,377076217
425;control;no-inhib(KCC);selectively ablating the K-Cl cotransporters;49,2;43,7;8;6,7;10;10;25,29822128;21,18726032;FALSCH;p=0.60;23,33345238;-0,235713083;-11,17886179;we observed no deficits in either context memory retention;no deficits;229;260;0,576297705;0,419038997;0,285693662;11,17886179;46,45;0,50233482;;;;;;;;;0,21;-5,5;0,596828862;0,284279633;0,373444136;0,073209713;0,200955551;0,432157628
426;control;no-inhib(KCC);selectively ablating the K-Cl cotransporters;37,7;22,6;9,9;7,8;10;10;31,30654884;24,66576575;FALSCH;p=0.17;28,18244134;-0,535794604;-40,0530504;we observed no deficits in either (..) nor in cue memory retention;no deficits;230;259;0,276538941;0,19974061;0,143113966;40,0530504;30,15;0,934741006;;;;;;;;;0,21;-15,1;0,446662926;0,209823399;0,273116435;0,073209713;0,200955551;0,432157628
427;WT;less-excit;k.o. of  P/Q-type Ca2-channels;41,6;40;2,9;2;10;9;9,170605214;6;FALSCH;p=0.67;7,839942977;-0,204083117;-3,846153846;we found no significant differences between genotypes in any of the mutant lines;no significant differences;231;261;0,999536706;0,990346136;0,926673776;3,846153846;40,84210526;0,191957367;;;;;;;;;0,64;-1,6;0,99999524;0,980423345;0,997295217;0,071974211;0,192823661;0,41350208
428;WT;no-inhibit;"selectively ablating the
 2 subunit of the GABAA-receptors";33,7;37,4;3,7;6,2;7;8;9,789279851;17,53624817;FALSCH;p=0.62;14,48505861;0,255435625;10,97922849;we found no significant differences between genotypes in any of the mutant lines;no significant differences;231;261;0,624557293;0,459200458;0,313689109;9,893048128;35,67333333;0,406047242;;;;;;;;;0,64;3,7;0,866365857;0,489231047;0,62490634;0,067276248;0,161858992;0,339585243
429;WT;No-LTP;calcium/calmodulin-activated protein-phosphatase-2B is selectively impaired;46,7;47,8;3,5;4,7;12;12;12,12435565;16,28127759;FALSCH;p=0.86;14,35409349;0,076633192;2,355460385;we found no significant differences between genotypes in any of the mutant lines;no significant differences;232;261;0,961107347;0,859230706;0,67350634;2,30125523;47,25;0,303790338;;;;;;;;;0,64;1,1;0,975387309;0,695930307;0,830134517;0,077917485;0,231827529;0,499895874
430;WT;No-LTD;pseudosubstrate PKC inhibitor, PKC[19–31], is selectively expressed;49,4;43,3;3,8;3,8;14;12;14,21829807;13,16358614;FALSCH;p=0.24;13,74493846;-0,443799732;-12,34817814;we found no significant differences between genotypes in any of the mutant lines;no significant differences;232;261;0,986467597;0,925255388;0,769983027;12,34817814;46,58461538;0,29505317;;;;;;;;;0,64;-6,1;0,989146317;0,764171985;0,884691431;0,080096985;0,246032902;0,529368422
431;B6;BTBR;model of autism spectrum disorder;17,23;18,3;2,79;2,8;10;10;8,822754672;8,854377448;FALSCH;NS;8,838580203;0,121060168;6,210098665;There were no differences between strains in the other conditions;no difference;233;262;0,561020238;0,406705706;0,277246712;5,846994536;17,765;0,497527734;3,58;6,26;2,8;4,83;;;;;0,14;1,07;0,999943613;0,955982363;0,99088951;0,073209713;0,200955551;0,432157628
432;B6;BTBR;model of autism spectrum disorder;60,86;36,73;4,39;5,61;10;10;13,88239893;17,74037767;WAHR;p<0.001;15,92862204;-1,514883079;-39,64837332;B6 mice froze significantly more in the 4P condition than the BTBR mice in the 4P condition;significantly more;233;263;0,973820485;0,888919723;0,713559521;39,64837332;48,795;0,326439636;3,59;2,97;1,27;0,5;;;;;0,71;-24,13;0,897991874;0,529586762;0,66921738;0,073209713;0,200955551;0,432157628
433;B6;BTBR;model of autism spectrum disorder;24,89;31,96;3,21;4,4;10;10;10,15091129;13,9140217;FALSCH;NS;12,17869041;0,580522188;28,40498192;There were no differences between strains in the other conditions;no difference;233;264;0,763864947;0,588909844;0,41049652;22,12140175;28,425;0,42844997;2,83;13,16;1,02;8,65;;;;;0,14;7,07;0,988237098;0,758185591;0,880204484;0,073209713;0,200955551;0,432157628
434;B6;BTBR;model of autism spectrum disorder;30,8;20,94;4,01;3,61;10;10;12,68073342;11,41582235;FALSCH;NS;12,06486635;-0,817249003;-32,01298701;essa comparação não é mencionada no texto;-;233;265;0,740834783;0,565655298;0,392287861;32,01298701;25,87;0,466365147;3,58;6,26;2,8;4,83;;;;;;-9,86;0,989406738;0,765950904;0,886013224;0,073209713;0,200955551;0,432157628
435;B6;BTBR;model of autism spectrum disorder;68,54;38,19;5,2;3,2;10;10;16,44384383;10,11928851;WAHR;p<0.001;13,65283853;-2,222980952;-44,28071199;the BTBR mice in the 4P group froze less than B6 mice in the 4P group during the cue presentation;less;233;266;0,999223204;0,986766637;0,912458783;44,28071199;53,365;0,255838818;3,59;2,97;1,27;0,5;;;;;0,43;-30,35;0,964745292;0,66028268;0,798818791;0,073209713;0,200955551;0,432157628
436;B6;BTBR;model of autism spectrum disorder;56,07;58,25;6,01;6,02;10;10;19,00528874;19,03691151;FALSCH;NS;19,0211067;0,114609525;3,887997146;essa comparação não é mencionada no texto;-;233;267;0,878195815;0,722219243;0,525090514;3,74248927;57,16;0,332769536;2,83;13,16;1,02;8,65;;;;;;2,18;0,771873877;0,398883609;0,519143447;0,073209713;0,200955551;0,432157628
437;ASIC +/+;ASIC1 -/-;k.o. of acid-sensing ion chanels;85,07;37,1;5,45;5,43;31;20;30,34431578;24,28369824;WAHR;p<0.05;28,14959564;-1,704109736;-56,38885624;Compared to wild-type controls, all three ASIC null genotypes also showed reduced freezing in response to cue;reduced;234;268;0,997815103;0,975173632;0,875473536;56,38885624;66,25823529;0,424846746;;;;;;;;;0,57;-47,97;0,813295723;0,434479455;0,561849363;0,107299559;0,414355017;0,796553894
438;ASIC +/+;ASIC2 -/-;k.o. of acid-sensing ion chanels;85,07;61,4;5,45;8,18;31;17;30,34431578;33,72700402;WAHR;p<0.05;31,56204993;-0,749951288;-27,82414482;Compared to wild-type controls, all three ASIC null genotypes also showed reduced freezing in response to cue;reduced;234;268;0,982870008;0,913875956;0,751188587;27,82414482;76,686875;0,411570428;;;;;;;;;0,57;-23,67;0,675702355;0,330667868;0,433830492;0,101631894;0,381009262;0,755163322
439;ASIC +/+;ASIC1/2 -/-;k.o. of acid-sensing ion chanels;85,07;19,56;5,45;3,44;31;21;30,34431578;15,76406039;WAHR;p<0.05;25,53172027;-2,565827892;-77,00717057;Compared to wild-type controls, all three ASIC null genotypes also showed reduced freezing in response to cue;reduced;234;268;0,999688978;0,992433151;0,936067173;77,00717057;58,61403846;0,435590533;;;;;;;;;0,57;-65,51;0,890430843;0,519217194;0,658013495;0,109047422;0,424422449;0,808024916
440;ASIC +/+;ASIC1 -/-;k.o. of acid-sensing ion chanels;20,8;7,61;2,63;2,05;26;20;13,41042132;9,167878708;WAHR;p<0.05;11,7675739;-1,120876751;-63,41346154;Compared to wild-type controls, all three A S I C n ull genotypes showed reduced freezing in response to context;reduced;235;269;0,774268851;0,599719221;0,419110787;63,41346154;15,06521739;0,781108801;;;;;;;;;0,57;-13,19;0,999998029;0,98537397;0,998250289;0,10319481;0,390309193;0,76724273
441;ASIC +/+;ASIC2 -/-;k.o. of acid-sensing ion chanels;20,8;3,8;2,63;1,17;26;17;13,41042132;4,824033582;WAHR;p<0.05;10,89677263;-1,560094955;-81,73076923;Compared to wild-type controls, all three A S I C n ull genotypes showed reduced freezing in response to context;reduced;235;269;0,797792223;0,624944922;0,439615196;81,73076923;14,07906977;0,773969645;;;;;;;;;0,57;-17;0,999999246;0,989370444;0,998913078;0,098272453;0,360761194;0,727385313
442;ASIC +/+;ASIC1/2 -/-;k.o. of acid-sensing ion chanels;20,8;5,85;2,63;1,46;26;12;13,41042132;5,057588358;WAHR;p<0.05;11,51973693;-1,297772692;-71,875;Compared to wild-type controls, all three A S I C n ull genotypes showed reduced freezing in response to context;reduced;235;269;0,656113258;0,48657994;0,333246306;71,875;16,07894737;0,716448451;;;;;;;;;0,57;-14,95;0,999916227;0,949938374;0,988945467;0,088392453;0,299351499;0,630200839
443;Sham;Incision;postoperative cognitive disfunction;25,6;13,42;3,7232;2,2592;15;15;14,41989159;8,749843976;WAHR;p=0.009;11,92671462;-1,021236811;-47,578125;The surgical incision reduced the freezing time of mice in the tone test of FCS at3d;reduced;236;270;0,765305433;0,590394621;0,411673941;47,578125;19,51;0,611312897;;;;;;;;;0,57;-12,18;0,999555672;0,914223531;0,975115642;0,085015664;0,277810304;0,591330511
444;Sham;Incision;postoperative cognitive disfunction;9,89;7,79;0,5376;0,4846;15;15;2,082115847;1,87684773;FALSCH;p=0.485;1,982140737;-1,059460593;-21,23356926;The surgical incision did not reduce the freezing timeofmiceinthecontexttestofFCSat 3d;not reduced;236;271;0,999990565;0,999117943;0,981076928;21,23356926;8,84;0,224224065;;;;;;;;;0,29;-2,1;1;1;1;0,085015664;0,277810304;0,591330511
445;Sham;Incision;postoperative cognitive disfunction;15,68;22,51;;;;;;;FALSCH;p=0.458;;;43,55867347;the surgical incision did not significantly reduce the freezing time in the tone test of FCS at 3 d;not significantly reduced;237;270;;;;30,34207019;;;;;;;;;;;0,29;6,83;;;;;;
446;Saline;Haloperidol;haloperidol-induced catalepsy;77,6;76,04;8,33;6,77;10;8;26,34177291;19,14845163;FALSCH;NS;23,46758855;-0,066474661;-2,010309278;revealed no significant effect on the time of freezing;no significant effect;238;272;0,889212142;0,737412518;0,539580028;2,010309278;76,90666667;0,305143749;;;;;;;;;0,21;-1,56;0,542679033;0,255735913;0,335436972;0,070603127;0,183790852;0,392399678